<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Complement Med Ther</journal-id><journal-id journal-id-type="iso-abbrev">BMC Complement Med Ther</journal-id><journal-title-group><journal-title>BMC Complementary Medicine and Therapies</journal-title></journal-title-group><issn pub-type="epub">2662-7671</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">12023620</article-id><article-id pub-id-type="pmid">40275320</article-id>
<article-id pub-id-type="publisher-id">4883</article-id><article-id pub-id-type="doi">10.1186/s12906-025-04883-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Evaluation of the antiproliferative, cytotoxic and phytochemical properties of Zimbabwean medicinal plants used in cancer treatment</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Mlilo</surname><given-names>Sigcono</given-names></name><address><email>sigconomlilo@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sibanda</surname><given-names>Samson</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sithole</surname><given-names>Simbarashe</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mukanganyama</surname><given-names>Stanley</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Naik</surname><given-names>Yogehkumar S.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02kesvt12</institution-id><institution-id institution-id-type="GRID">grid.440812.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0648 4616</institution-id><institution>Department of Applied Chemistry, </institution><institution>National University of Science and Technology (NUST), </institution></institution-wrap>P.O.Box AC 939, Ascot, Bulawayo, Zimbabwe </aff><aff id="Aff2"><label>2</label>Department of Soil Science and Productivity, Sciences and Technology (MUAST), Marondera University of Agricultural, P.O Box 35, Marondera, Zimbabwe </aff><aff id="Aff3"><label>3</label>African Institute of Biomedical Science and Technology 911 Boronia Farm, Beatrice, Zimbabwe </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02kesvt12</institution-id><institution-id institution-id-type="GRID">grid.440812.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0648 4616</institution-id><institution>Environmental Science, </institution><institution>National University of Science and Technology (NUST), </institution></institution-wrap>Bulawayo, Zimbabwe </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><elocation-id>156</elocation-id><history><date date-type="received"><day>11</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>3</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Cancer cases have been on the rise globally and several treatment strategies have been developed but mortality rates remain high. Zimbabwe, like many other countries, has also experienced a surge in cancer cases. In Zimbabwe, medicinal plants have been widely used to treat cancer for centuries. However, there has been limited research on the effectiveness, safety, and chemical composition of these plants. The current study assessed antiproliferative, cytotoxic and phytochemical properties of selected Zimbabwean medicinal plants.</p></sec><sec><title>Method</title><p id="Par2">Cytotoxic activity of <italic>Agelenthus pungu</italic>, <italic>Carissa edulis</italic>, <italic>Dombeya rotundifolia</italic>, <italic>Flacourtia indica</italic>, <italic>Lannea discolor</italic>, <italic>Leonotis ocymifolia</italic>, <italic>Leucas martinicensis</italic>, <italic>Plicosepalus kalachariensis</italic>, <italic>Pseudolachnostylis maproneifolia</italic>, <italic>Solanum incanum</italic>, <italic>Strychnos cocculoides</italic>, <italic>Strychnos spinosa</italic> and <italic>Viscum verrucosum</italic> extracts were evaluated on normal murine peritoneal cells and sheep erythrocytes while antiproliferative activity was assessed on Jurkat T and HL60 cell lines. Cell viability was determined using the trypan blue exclusion and sulforhodamine B assay. Additionally, the effect of reduced glutathione on cytotoxic extracts was examined. The phytochemicals of the methanolic extracts were qualitatively determined using standard methods.</p></sec><sec><title>Results</title><p id="Par3"><italic>Agelenthus pungu</italic>, <italic>Carissa edulis</italic>, <italic>Flacourtia indica</italic>, <italic>Strychnos cocculoides</italic>, <italic>Strychnos spinosa</italic> and <italic>Viscum verrucosum</italic> were cytotoxic to normal murine peritoneal cells. <italic>Flacourtia indica</italic> and <italic>Viscum verruscosum</italic> caused haemolysis of sheep erythrocytes at a concentration of 250&#x000a0;&#x000b5;g/mL for both plant extracts and 125&#x000a0;&#x000b5;g/mL for <italic>Viscum verrucosum</italic>. Cell viability increased on addition of 25&#x000a0;&#x000b5;g/mL of reduced glutathione to the extracts considered the most cytotoxic extracts, <italic>Agelenthus pungu</italic> and <italic>Viscum verrucosum</italic>. <italic>Agelenthus pungu</italic>, <italic>Carissa edulis</italic>, <italic>Leonotis ocymifolia</italic>, <italic>Leucas martinicensis</italic> and <italic>Viscum verrucosum</italic> significantly inhibited Jurkat T and HL60 cell proliferation. <italic>Viscum verrucosum</italic> was the most potent with the lowest half-maximum inhibitory concentration (IC<sub>50</sub>) values of 33 and 34&#x000a0;&#x000b5;g/mL on Jurkat T and HL60 cell lines respectively. The most dominant phytochemical classes were alkaloids, flavonoids and saponins.</p></sec><sec><title>Conclusion</title><p id="Par4">This study demonstrates that <italic>Agelenthus pungu</italic>, <italic>Carissa edulis</italic>, <italic>Leonotis ocymifolia</italic>, <italic>Leucas martinicensis</italic> and <italic>Viscum verrucosum</italic> have antiproliferative activity against Jurkat T and HL60 cell lines. <italic>Viscum verrucosum</italic> was the most potent. These findings emphasise the importance of medicinal plants as well as their potential use as sources of novel compounds in anticancer drug discovery.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Medicinal plants</kwd><kwd>Cancer</kwd><kwd>Antiproliferative</kwd><kwd>Cytotoxicity</kwd><kwd>Phytochemistry</kwd><kwd><italic>Viscum verrucosum</italic></kwd><kwd>Zimbabwe</kwd></kwd-group><funding-group><award-group><funding-source><institution>National University of Science and Technology, Zimbabwe</institution></funding-source><award-id>RB/56/16, 57/16, and 19/17</award-id><principal-award-recipient><name><surname>Sibanda</surname><given-names>Samson</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par19">Cancer is a leading cause of death in the world, with the cancer burden being greater in developing countries [<xref ref-type="bibr" rid="CR1">1</xref>]. It is estimated that 70% of cancer deaths occur in developing countries [<xref ref-type="bibr" rid="CR2">2</xref>]. This is largely due to poverty, limited healthcare access and inadequate cancer treatment resources [<xref ref-type="bibr" rid="CR3">3</xref>]. In 2020, Zimbabwe had 16,083 cancer cases and 10,676 cancer deaths, according to a World Health Organization (WHO) report [<xref ref-type="bibr" rid="CR4">4</xref>]. Cancers such as breast cancer, cervical cancer, lung cancer, Kaposi sarcoma, prostate cancer, and leukaemia contribute to the cancer burden in Zimbabwe [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par20">Leukaemia is the most common childhood cancer, accounting for 30% of all cancer cases diagnosed in children under the age of fifteen [<xref ref-type="bibr" rid="CR6">6</xref>]. It is a type of cancer that affects white blood cells. It starts when the bone marrow produces abnormal white blood cells that fail to function properly leading to the body's inability to fight infections. Chemotherapy typically serves as the primary treatment option for leukaemia. It involves administering drugs aimed at eradicating or impeding the proliferation of cancer cells [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par21">Despite the effectiveness of chemotherapy in destroying cancer cells, this method may have some drawbacks, as some cancer cells may become resistant to the drugs. Furthermore, most chemotherapeutic drugs damage both normal and cancerous cells, leading to other health problems [<xref ref-type="bibr" rid="CR8">8</xref>]. To alleviate the drawbacks of chemotherapy, patients resort to herbal remedies or antioxidant supplements. These complementary treatments have shown promising activity in enhancing the effectiveness of chemotherapy and minimising damage to normal cells [<xref ref-type="bibr" rid="CR9">9</xref>]. Alternative treatment options, such as radiation, targeted therapy, stem cell transplant, immunotherapy, and gene therapy are often considered for leukaemia treatment [<xref ref-type="bibr" rid="CR10">10</xref>]. However, in Zimbabwe, despite advancements in treatment, accessibility and affordability remain notable challenges.</p><p id="Par22">In Zimbabwe, over 75% of the population relies on medicinal plants for primary healthcare [<xref ref-type="bibr" rid="CR11">11</xref>]. For centuries, medicinal plants have been used to treat various ailments and their use in cancer treatment has recently gained global attention. It is estimated that 60% of cancer drugs are plant-based [<xref ref-type="bibr" rid="CR12">12</xref>]. These plant-based cancer drugs belong to various phytochemical classes, such as alkaloids, flavonoids, terpenoids, and polyphenols. Each class exhibits unique properties and can reduce cancer cell proliferation via several mechanisms of action, making them valuable assets in the fight against cancer [<xref ref-type="bibr" rid="CR13">13</xref>]. As a result, research continues to explore the potential of phytochemicals in developing effective cancer therapies.</p><p id="Par23">A significant contribution made by Mlilo and Sibanda [<xref ref-type="bibr" rid="CR14">14</xref>] was the cataloguing of plants traditionally used for the treatment and management of cancer in Matebeleland, Zimbabwe. Based on the results and recommendations of this study, we evaluated the effectiveness of these documented medicinal plants as potential in vitro leukaemia remedies. By assessing the plants&#x02019; ability to inhibit cancer cell proliferation, toxicity to normal cells, and analysing for the presence of different classes of bioactive compounds. The study aimed to identify plants with potential for advancement in cancer therapy research and development.</p></sec><sec id="Sec2"><title>Materials and Methods</title><sec id="Sec3"><title>Chemicals</title><p id="Par24">Analytical-grade chemicals and drugs were purchased from Sigma-Aldrich (Steinheim, Germany) for the study. This included methanol, Foetal Bovine Serum (FBS), Roswell Park Memorial Institute 1640 media (RPMI), reduced-glutathione (GSH), penicillin and streptomycin solution (PNS), Hanks Buffered Saline Solution (HBSS), foetal calf serum (FCS), trichloroacetic acid (TCA), sulforhodamine B (SRB), trizma base, sodium hypochlorite, dimethyl sulfoxide (DMSO), trypan blue dye, chlorambucil, camptothecin and phytochemical screening reagents.</p></sec><sec id="Sec4"><title>Collection and authentication of plant material</title><p id="Par25">The plant species were collected from five districts of the Matebeleland region (Bulawayo, Gwanda, Hwange, Matobo and Tsholotsho) between September and December 2018. Approval to collect plant samples was sought from the relevant Rural District Councils (RDC) and Community Leaders. The samples were collected using sustainable harvesting methods to minimise the impact on biodiversity. Plant specimens were deposited at the Zimbabwe National Herbarium and Botanical Garden in Harare, Zimbabwe, for identification and authentication. The plants were identified by Anthony Mapaura and deposited specimens were filed by Christopher Chapano. Table <xref rid="Tab1" ref-type="table">1</xref> provides a comprehensive list of collected species along with the plant parts used and their corresponding specimen numbers.
<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>List of medicinal plants used traditionally in Zimbabwe for the treatment of cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Scientific name</th><th align="left">Family name</th><th align="left">Specimen number</th><th align="left">Local name</th><th align="left">Medicinal part used</th><th align="left">Percentage yield (%)</th></tr></thead><tbody><tr><td align="left"><italic>Agelanthus pungu</italic> (De Wild.) Polhill and Wiens</td><td align="left">Loranthaceae</td><td align="left">ML011</td><td align="left">Inofi yephane</td><td align="left">Whole plant</td><td char="." align="char">5.76</td></tr><tr><td align="left"><italic>Carissa edulis</italic> (Forssk.) Vahl</td><td align="left">Apocynaceae</td><td align="left">ML005</td><td align="left">Umlugulu</td><td align="left">Root bark</td><td char="." align="char">22.95</td></tr><tr><td align="left"><italic>Dombeya rotundifolia</italic> (Hochst.) Planch</td><td align="left">Malvaceae</td><td align="left">ML004</td><td align="left">Umwane</td><td align="left">Stem bark</td><td char="." align="char">34.38</td></tr><tr><td align="left"><italic>Flacourtia indica</italic> (Burm.f.) Merr</td><td align="left">Salicaceae</td><td align="left">ML006</td><td align="left">Umqokolo</td><td align="left">Stem bark</td><td char="." align="char">15.33</td></tr><tr><td align="left"><italic>Lannea discolor</italic> (Sond.) Engl</td><td align="left">Anacardiaceae</td><td align="left">ML008</td><td align="left">Isigangatsha</td><td align="left">Stem bark</td><td char="." align="char">9.01</td></tr><tr><td align="left"><italic>Leonotis ocymifolia</italic> (Burm.f.) Iwaesson</td><td align="left">Lamiaceae</td><td align="left">ML002</td><td align="left">Ulujulwenyoni</td><td align="left">Whole plant</td><td char="." align="char">8.22</td></tr><tr><td align="left"><italic>Leucas martinicensis</italic> R.Br</td><td align="left">Lamiaceae</td><td align="left">ML003</td><td align="left">Ulujulwenyoni</td><td align="left">Whole plant</td><td char="." align="char">12.45</td></tr><tr><td align="left"><italic>Plicosepalus kalachariensis</italic> (Schinz) Danser</td><td align="left">Loranthaceae</td><td align="left">ML010</td><td align="left">Igumalala lephane</td><td align="left">Whole plant</td><td char="." align="char">8.97</td></tr><tr><td align="left"><italic>Pseudolachnostylis maprouneifolia</italic> Pax</td><td align="left">Phyllanthaceae</td><td align="left">ML012</td><td align="left">Umqhobampunzi</td><td align="left">Stem bark</td><td char="." align="char">19.20</td></tr><tr><td align="left"><italic>Solanum incanum</italic> L</td><td align="left">Solanaceae</td><td align="left">ML007</td><td align="left">Intume enkulu</td><td align="left">Fruits</td><td char="." align="char">25.79</td></tr><tr><td align="left"><italic>Strychnos cocculoides</italic> Baker</td><td align="left">Loganiaceae</td><td align="left">ML013</td><td align="left">Umkhemeswane</td><td align="left">Stem bark</td><td char="." align="char">28.75</td></tr><tr><td align="left"><italic>Strychnos spinosa</italic> Lam</td><td align="left">Loganiaceae</td><td align="left">ML001</td><td align="left">Umzhume/Umhlali</td><td align="left">Stem bark</td><td char="." align="char">23.18</td></tr><tr><td align="left"><italic>Viscum verrucosum</italic> Harv</td><td align="left">Santalaceae</td><td align="left">ML009</td><td align="left">Igumalala lephane</td><td align="left">Whole plant</td><td char="." align="char">11.23</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec5"><title>Extraction of plant material</title><p id="Par26">Fresh leaves, stem barks, fruits, tubers, or roots were collected from September to December 2018 using traditional sampling methods. These plants were first washed with distilled water to remove soil and dust particles. The plant materials were air-dried at room temperature (25 &#x02013; 30&#x02103;) in the shade, pulverised into a fine powder with a blender (MRC Laboratory Blender model 800-G, Waring Commercial) and kept in sealed containers in the dark until required for analysis. Maceration was employed as a method of extraction using methanol solvent. Known weights (200&#x000a0;g) of powdered material were loaded onto a fritted glass column. The material was allowed to stand in 1000&#x000a0;mL of methanol for 24&#x000a0;h to allow the soluble phytochemicals to dissolve. The extract was filtered after 24&#x000a0;h and fresh solvent was added and this procedure was repeated twice. The solvent was removed using a rotary evaporator at 37&#x02103;. The dry samples were placed in airtight sample tubes and kept in the fridge at -4&#x02103; until needed.</p></sec><sec id="Sec6"><title>The cytotoxic effects of crude methanolic plant extracts on normal animal cells</title><p id="Par27">Animal cells were used in the experimental work and researchers prioritised animal welfare and ensured responsible experimental designs were followed. All tissue culture experiments were carried out following relevant ethical regulations. Experimental protocols used in this study were approved by the National University of Science and Technology Ethics Committee (NUST/IRB/2022/48).</p><sec id="Sec7"><title>The cytotoxic effect of methanolic plant extracts on normal murine peritoneal cells</title><p id="Par28">Mice used in this study were obtained from the University of Zimbabwe Animal House. The normal murine peritoneal cells were isolated from 6&#x02013;8&#x000a0;week-old mice using a method previously described by Ray and Dittel [<xref ref-type="bibr" rid="CR15">15</xref>]. To increase peritoneal cell yield, 1&#x000a0;mL of starch solution (20%) was injected intraperitoneally into male Balb/C mice (31&#x02009;&#x000b1;&#x02009;3&#x000a0;g) and left for 24&#x000a0;h. The mouse was euthanised by cervical dislocation and this was performed by trained personnel to ensure compliance with ethical standards. The mouse was then sprayed with 70% ethanol and mounted on a styrofoam board on its back. The outer peritoneum skin was cut using scissors and forceps and gently pulled, exposing the inner peritoneal skin. Cold PBS with 3% FBS (5&#x000a0;mL) was injected into the peritoneal cavity without puncturing any organs. The peritoneum was then massaged to remove any attached cells to the PBS. A 25&#x000a0;g needle was inserted, bevelled up, and attached to a 10&#x000a0;mL syringe in the peritoneum. This was done to extract as much fluid as possible. The collected fluid was put into tubes kept on ice. An incision was made in the inner skin to collect the remaining peritoneal fluid from the cavity. Samples with visible blood contamination were discarded. The collected suspension was centrifuged for 10&#x000a0;min at 1500&#x000a0;rpm in a Hettich Rotofix 32 centrifuge (Tuttlingen, Germany). The supernatant was discarded, and the cells were resuspended in RPMI and incubated overnight at 37&#x02103; in a 5% CO<sub>2</sub> Shel lab incubator (CO<sub>2</sub> series Sheldon Mfg. Inc, Cornelius, USA). Cells were exposed to 0.4% trypan blue and manually counted with a haemocytometer counting chamber under a Celestron digital light microscope (Celestron, Los Angeles, USA) using a&#x02009;&#x000d7;&#x02009;10 objective lens. The crude methanolic extracts of <italic>A. pungu</italic>, <italic>C. edulis</italic>, <italic>D. rotundifolia</italic>, <italic>F. indica</italic>, <italic>L. discolor</italic>, <italic>L. ocymifolia</italic>, <italic>L. martinicensis</italic>, <italic>P. kalachariensis</italic>, <italic>P. maproneifolia</italic>, <italic>S. incanum</italic>, <italic>S. cocculoides</italic>, <italic>S. spinosa</italic> and <italic>V. verrucosum</italic> were prepared in triplicates with the highest concentration being 250&#x000a0;&#x000b5;g/mL. This concentration was chosen due to the insolubility observed in some extracts at higher concentrations. To ensure consistency, this concentration was applied uniformly across all extracts in this study. The cells (1&#x02009;&#x000d7;&#x02009;10<sup>4</sup> per well) and test solutions were incubated for 72&#x000a0;h at 37&#x02103; in a 5% CO<sub>2</sub> Shel Lab incubator (CO<sub>2</sub> series Sheldon Mfg. Inc, Cornelius, USA). This was followed by staining the cells with 0.4% trypan blue dye and counting using a haemocytometer counting chamber under a Celestron digital light microscope. The extracts that were found to be cytotoxic were subjected to a concentration-dependent assay in triplicates at the following concentrations: 0, 32, 63, 125, and 250&#x000a0;&#x003bc;g/mL.</p></sec><sec id="Sec8"><title>The cytotoxic effect of methanolic plant extracts on sheep erythrocytes</title><p id="Par29">Sheep erythrocytes were used in this assay and were obtained from the University of Zimbabwe Animal House. The haemolysis assay was conducted according to the procedure previously documented by Mapfunde et al. [<xref ref-type="bibr" rid="CR16">16</xref>]. The assay was performed on the following concentrations of the methanolic plant extracts: 0, 32, 63, 125, and 250&#x000a0;&#x003bc;g/mL. A volume of 50&#x000a0;mL of sheep blood was collected under the guidance of veterinary experts. The blood was placed in a flask and an equal volume of Alsever solution was immediately added. Blood was centrifuged at 3000&#x000a0;rpm for 10&#x000a0;min. The supernatant was discarded, and the residue was washed three times with 1:5 volume of PBS by centrifuging at 4000&#x000a0;rpm for 5&#x000a0;min in a Rotofix 32 centrifuge. The supernatant was discarded. Cells were diluted four folds with PBS and the resulting suspension was used to determine haemolysis. A volume of 500 &#x000b5;L was incubated with 500 &#x000b5;L of the test sample extract in PBS for 90&#x000a0;min at 37&#x02103;. After incubation, the tubes were spun in a microcentrifuge at 3000&#x000a0;rpm for 1&#x000a0;min. The resulting supernatant 200 &#x000b5;L was added to 3&#x000a0;mL of Drabkin&#x02019;s reagent. The positive control consisted of a 500 &#x000b5;L uncentrifuged mixture of erythrocyte suspension and 500 &#x000b5;L of PBS from which 400 &#x000b5;L was added to 3&#x000a0;mL Drabkin&#x02019;s reagent to obtain 100% haemolysis. The negative control was used to measure the level of spontaneous haemolysis and thus was made by mixing 500 &#x000b5;L of erythrocyte suspension and 500 &#x000b5;L of buffer, centrifuging at 3000&#x000a0;rpm for 60&#x000a0;s then adding 200 &#x000b5;L of supernatant to 3&#x000a0;mL of Drabkin&#x02019;s reagent. Aliquots of 200 &#x000b5;L of the supernatant in Drabkin&#x02019;s reagent were placed in round-bottomed 96-well plates to determine the amount of haemoglobin released, the absorbance was read at 590&#x000a0;nm. The percentage of haemolysis was calculated using Eq.&#x000a0;<xref rid="Equ1" ref-type="disp-formula">1</xref>.<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="d33e768">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Percentage\;Haemolysis=\frac{\left(Sample\;absorbance-Negative\;control\;absorbance\right)}{(Positive\;control\;absorbance-Negative\;control\;absorbance)}x10$$\end{document}</tex-math><mml:math id="d33e774" display="block"><mml:mrow><mml:mi>P</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.277778em"/><mml:mi>H</mml:mi><mml:mi>a</mml:mi><mml:mi>e</mml:mi><mml:mi>m</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>y</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mi>S</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.277778em"/><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mo>-</mml:mo><mml:mi>N</mml:mi><mml:mi>e</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.277778em"/><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.277778em"/><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi></mml:mfenced><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>P</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.277778em"/><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.277778em"/><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mo>-</mml:mo><mml:mi>N</mml:mi><mml:mi>e</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.277778em"/><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.277778em"/><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:mi>x</mml:mi><mml:mn>10</mml:mn></mml:mrow></mml:math><graphic xlink:href="12906_2025_4883_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p></sec><sec id="Sec9"><title>Effect of reduced-glutathione (GSH) on crude plant extracts</title><p id="Par30">The effect of GSH on the activity of the most cytotoxic methanolic extracts on normal murine peritoneal cells was investigated. To a 12-well plate, the following samples were added in triplicates: cells only; cells&#x02009;+&#x02009;GSH; cells&#x02009;+&#x02009;extract; cells&#x02009;+&#x02009;extract&#x02009;+&#x02009;GSH. The GSH concentration utilised was 25&#x000a0;&#x000b5;g/mL, while the plant extracts were tested at their highest concentration of 250&#x000a0;&#x000b5;g/mL. The plates were incubated at 37&#x02103; with 5% CO&#x02082; for 72&#x000a0;h. The Trypan blue dye exclusion method was used to count the number of viable cells.</p></sec></sec><sec id="Sec10"><title>The antiproliferative effect of methanolic plant extracts on cancer cell lines</title><sec id="Sec11"><title>The effect of crude methanolic plant extracts on Jurkat T cell lines</title><p id="Par31">The in vitro antiproliferative activity was assessed on Jurkat E6-1 human leukaemic T lymphoblastoid cell lines (Hudson Alpha/Caltech ENODE). The cells were grown in RPMI-1640 media supplemented with 10% FBS and 1% PNS solution at 37&#x02103; with 5% CO<sub>2</sub> in an incubator (Shel Lab CO<sub>2</sub> Series, Sheldon Mfg. Inc., Cornelius, USA). The antiproliferative effect of the thirteen extracts was evaluated using the Trypan blue exclusion assay as previously described by Machingauta et al. [<xref ref-type="bibr" rid="CR17">17</xref>]. The extracts were first tested at the highest concentration of 250&#x000a0;&#x003bc;g/mL and 10&#x000a0;&#x000b5;g/mL chlorambucil was used as a positive control. Wells with cells only were used as negative controls to ensure that any observed antiproliferative effect was not due to factors other than the tested compounds. To determine half-maximal inhibitory concentration (IC<sub>50</sub>) the extracts that were considered antiproliferative were further subjected to the following concentrations: 0, 32, 63, 125, and 250&#x000a0;&#x003bc;g/mL, with all experiments conducted in triplets.</p></sec><sec id="Sec12"><title>The effect of crude methanolic plant extracts on HL60 cell lines</title><p id="Par32">The antiproliferative effect of extracts was assessed on HL60 cell lines (European Collection of Authenticated Cell Cultures; (ECACC), U K). A colourimetric SRB assay was used to assess growth inhibition in a manner previously described by Skehan et al., with minor modifications [<xref ref-type="bibr" rid="CR18">18</xref>]. All thirteen extracts were first tested at the highest concentration of 250&#x000a0;&#x000b5;g/mL, and 10&#x000a0;&#x000b5;g/mL of camptothecin served as a positive control. Wells containing cells only served as a negative control. A concentration-dependent assay (0, 32, 63, 125, 250&#x000a0;&#x000b5;g/mL) was conducted on extracts that showed significant antiproliferative effects and IC<sub>50</sub> values were determined. All experiments were done in triplicates.</p></sec></sec><sec id="Sec13"><title>Selectivity index</title><p id="Par33">Selectivity index (SI) was calculated for the most cytotoxic extracts, this was done to assess the safety of the extracts [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. It was calculated using the following Eq.&#x000a0;(<xref rid="Equ2" ref-type="disp-formula">2</xref>):<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="d33e960">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$SI=\frac{{IC}_{50}\;of\;Extracts\;on\;Normal\;Murine\;Peritoneal\;Cells}{{IC}_{50}\;of\;Extracts\;on\;Cancer\;Cells}$$\end{document}</tex-math><mml:math id="d33e966" display="block"><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">IC</mml:mi></mml:mrow><mml:mn>50</mml:mn></mml:msub><mml:mspace width="0.277778em"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.277778em"/><mml:mi>E</mml:mi><mml:mi>x</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>s</mml:mi><mml:mspace width="0.277778em"/><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width="0.277778em"/><mml:mi>N</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.277778em"/><mml:mi>M</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.277778em"/><mml:mi>P</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.277778em"/><mml:mi>C</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="italic">IC</mml:mi></mml:mrow><mml:mn>50</mml:mn></mml:msub><mml:mspace width="0.277778em"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.277778em"/><mml:mi>E</mml:mi><mml:mi>x</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>s</mml:mi><mml:mspace width="0.277778em"/><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width="0.277778em"/><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width="0.277778em"/><mml:mi>C</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12906_2025_4883_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula></p></sec><sec id="Sec14"><title>Phytochemical screening</title><p id="Par34">The methanolic plant extracts were screened for various phytoconstituents. Screening was done for the following phytoconstituents: alkaloids, saponins, phenolic compounds, steroids, phytosteroids, anthraquinones, terpenoids, quinones, tannins, and coumarins. The tests were conducted according to standard methods by Guevara; and Harbone [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. The qualitative results are expressed as (&#x02009;+) for the presence and (&#x02009;&#x02212;) for the absence of phytochemicals.</p></sec><sec id="Sec15"><title>Data analysis</title><p id="Par35">GraphPad Prism 8 for Windows (GraphPad Software Inc., San Diego, California, USA) version 8.02 was used to analyse the results using a one-way analysis of variance test (ANOVA) with Dunnett&#x02019;s Multiple Comparison Test. Values with a <italic>P</italic>-value of 0.05 or less were considered statistically significant.</p></sec></sec><sec id="Sec16"><title>Results</title><sec id="Sec17"><title>Extraction of plant material</title><p id="Par36">A total of thirteen medicinal plant species were selected from a previous ethnobotanical survey conducted by Mlilo and Sibanda [<xref ref-type="bibr" rid="CR14">14</xref>] for antiproliferative, cytotoxic and phytochemical screening. The selection was based on the availability of plant samples, which ensured that enough material was available for screening purposes. In addition, literature searches were performed on plant species to ensure all plants with therapeutic potential were included in the analysis. Table <xref rid="Tab1" ref-type="table">1</xref> lists the plants screened, (botanical, family and local isiNdebele names are included as additional information) and percentage yields which were obtained following extraction with methanol.</p></sec><sec id="Sec18"><title>The cytotoxic effects of methanolic plant extracts on normal cells</title><sec id="Sec19"><title>The effects of extracts on normal murine peritoneal cells</title><p id="Par37">The cytotoxic effects of thirteen plant methanolic extracts on normal murine peritoneal cells are shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. The plant extracts (<italic>A. pungu</italic>, <italic>C. edulis</italic>, <italic>F. indica</italic>, <italic>S. cocculoides</italic>, <italic>S. spinosa</italic> and <italic>V. verrucosum</italic>) were cytotoxic on normal murine peritoneal cells at a concentration of 250&#x000a0;&#x000b5;g/mL. The results showed a significant difference between the untreated cells and those subjected to treatment, with a P-value&#x02009;&#x0003c;&#x02009;0.0001. Four plant extracts, including <italic>A. pungu</italic>, <italic>F. indica</italic>, <italic>S. spinosa</italic> and <italic>V. verrucosum</italic> which demonstrated a reduction in cell viability exceeding 40%, underwent a concentration-dependent assay as illustrated in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. The resulting IC<sub>50</sub> values are shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>The effect of crude methanolic plant extracts on normal murine peritoneal cells. Crude methanolic plant extracts were tested on normal murine peritoneal cells for their cytotoxic activity at a concentration of 250&#x000a0;&#x000b5;g/mL and chlorambucil was used as a positive control at a concentration of 10&#x000a0;&#x003bc;g/mL. The negative control contained cells and RPMI media only. The cells were incubated with test solutions and cell viability was determined after 72&#x000a0;h. The values are for mean&#x02009;&#x000b1;&#x02009;SD for <italic>n</italic>&#x02009;=&#x02009;3. All treatments were compared to cells only to determine the significant difference. The level of significance was denoted as follows: ****P&#x02009;&#x0003c;&#x02009;0.0001. Methanolic plant extracts (<italic>A. pungu</italic>, <italic>C. edulis</italic>, <italic>F. indica</italic>, <italic>S. cocculoides</italic>, <italic>S. spinosa</italic> and <italic>V.&#x000a0;verrucosum</italic>) significantly reduced cell viability and they were considered cytotoxic</p></caption><graphic xlink:href="12906_2025_4883_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Concentration-dependant effect of plant methanolic extracts on normal murine peritoneal cells. The cells were incubated with test solutions at a varying concentration from 32 to 250&#x000a0;&#x003bc;g/mL and cell viability was determined after 72&#x000a0;h. Chlorambucil was used as a positive control at a concentration from 1.25 to 10&#x000a0;&#x003bc;g/mL. The negative control contained cells and RPMI media only. The cell viability decreased with an increase in the concentration of the test extract</p></caption><graphic xlink:href="12906_2025_4883_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Half-maximum inhibitory concentration (IC<sub>50</sub>) values (&#x003bc;g/mL) and selectivity index of the potent methanolic plant extracts</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Scientific name</th><th align="left">IC<sub>50</sub> Jurkat<break/>(&#x003bc;g/mL, <italic>n</italic>&#x02009;=&#x02009;3)</th><th align="left">IC<sub>50</sub> HL60<break/>(&#x000b5;g/mL, <italic>n</italic>&#x02009;=&#x02009;3)</th><th align="left">IC<sub>50</sub> Normal Murine Peritoneal<break/>(&#x003bc;g/mL, <italic>n</italic>&#x02009;=&#x02009;3)</th><th align="left">Selectivity Index<break/>Jurkat</th><th align="left">Selectivity Index<break/>HL60</th></tr></thead><tbody><tr><td align="left"><italic>Agelenthus pungu</italic></td><td char="." align="char">92<sup>d</sup>&#x02009;&#x000b1;&#x02009;1.91</td><td align="left">93<sup>d</sup>&#x02009;&#x000b1;&#x02009;0.36</td><td align="left">143&#x02009;&#x000b1;&#x02009;0.42</td><td align="left">2</td><td align="left">2</td></tr><tr><td align="left"><italic>Carissa edulis</italic></td><td char="." align="char">241<sup>a</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">&#x02009;&#x0003e;&#x02009;250</td><td align="left">&#x02009;&#x0003e;&#x02009;250</td><td align="left">-</td><td align="left">-</td></tr><tr><td align="left"><italic>Leonotis ocymifolia</italic></td><td char="." align="char">175<sup>b</sup>&#x02009;&#x000b1;&#x02009;1.0</td><td align="left">133<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.55</td><td align="left">&#x02009;&#x0003e;&#x02009;250</td><td align="left">-</td><td align="left">-</td></tr><tr><td align="left"><italic>Leucas martinicensis</italic></td><td char="." align="char">172<sup>b</sup>&#x02009;&#x000b1;&#x02009;2.24</td><td align="left">152<sup>b.c</sup>&#x02009;&#x000b1;&#x02009;0.95</td><td align="left">&#x02009;&#x0003e;&#x02009;250</td><td align="left">-</td><td align="left">-</td></tr><tr><td align="left"><italic>Viscum verrucosum</italic></td><td char="." align="char">33<sup>e</sup>&#x02009;&#x000b1;&#x02009;0.39</td><td align="left">34<sup>e</sup>&#x02009;&#x000b1;&#x02009;0.27</td><td align="left">134&#x02009;&#x000b1;&#x02009;0.27</td><td align="left">4</td><td align="left">4</td></tr></tbody></table><table-wrap-foot><p>Values with different superscript letters are significantly different at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec20"><title>The effect of methanolic plant extracts on sheep erythrocytes</title><p id="Par38">Haemolysis assay was conducted on the four plant extracts <italic>A. pungu</italic>, <italic>F. indica</italic>, <italic>S. spinosa</italic> and <italic>V. verrucosum</italic> and their haemolytic activities are shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. Extracts were considered to be haemolytic if the percentage of haemolysis was greater than 30%. The <italic>A. pungu</italic> and <italic>S. spinosa</italic> extracts exhibited low haemolytic activity of less than 30% at all concentrations. <italic>F. indica</italic> exhibited haemolytic activity above 30% at the highest concentration 250&#x000a0;&#x000b5;g/mL, while <italic>V. verrucosum</italic> showed haemolytic activity above 30% at the highest concentration at both 125&#x000a0;&#x000b5;g/mL and 250&#x000a0;&#x000b5;g/mL.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>The haemolytic effect of crude methanolic plant extracts on sheep erythrocytes. The erythrocyte suspension was incubated with an equal volume of test samples dissolved in PBS at a concentration range of 32 to 250&#x000a0;&#x003bc;g/mL at 37&#x02103;. Methanolic plant extracts had greater haemolytic activity at higher concentrations. <italic>F</italic>. <italic>indica</italic> and <italic>V. verrucosum</italic> methanolic extracts caused haemolysis at the highest concentration of 250&#x000a0;&#x003bc;g/mL, with <italic>V. verrucosum</italic> also exhibiting haemolytic activity at 125&#x000a0;&#x003bc;g/mL</p></caption><graphic xlink:href="12906_2025_4883_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec21"><title>The effect of reduced-glutathione (GSH) on the activity of cytotoxic extracts on normal murine peritoneal cells</title><p id="Par39">The effects of GSH were investigated on the extracts which reduced cell viability of normal murine peritoneal cells by more than 50%, specifically <italic>A. pungu</italic> and <italic>V. verrucosum</italic>. The effects of GSH were investigated at the highest extract concentration of 250&#x000a0;&#x003bc;g/mL. As depicted in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>, the addition of GSH to the extracts of <italic>A. pungu</italic> and <italic>V. verrucosum</italic> to a noteworthy enhancement in cell viability.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>The effect of reduced&#x02014;glutathione (GSH) on the cytotoxic activity of <italic>A.pungu</italic> and <italic>V. verrucosum</italic>. The effect of combining GSH and crude methanolic plant extracts of <italic>A. pungu</italic> and <italic>V. verrucosum</italic> was evaluated on normal murine peritoneal cells. GSH and crude methanolic plant extracts were used at concentration of 25 and 250&#x000a0;&#x000b5;g/mL respectively. The cells were incubated with the test solution and cell viability was determined after 72&#x000a0;h. To determine significance (cells&#x02009;+&#x02009;extracts) was compared with (cells&#x02009;+&#x02009;extracts&#x02009;+&#x02009;GSH). ****P&#x02009;&#x0003c;&#x02009;0.0001 and *** P 0.0001. The addition of GSH to <italic>A. pungu</italic> and <italic>V. verrucosum</italic> increased the percentage of viable normal murine peritoneal cells</p></caption><graphic xlink:href="12906_2025_4883_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec22"><title>The antiproliferative effect of methanolic plant extracts on cancer cell lines</title><sec id="Sec23"><title>The effect of plant extracts on Jurkat T cell lines</title><p id="Par40">A total of thirteen crude methanolic plant extracts were subjected to the antiproliferation assay on Jurkat T cell lines at a concentration of 250&#x000a0;&#x000b5;g/mL, the results are shown in Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>. Eight methanolic plant extracts (<italic>A. pungu</italic>, <italic>C. edulis</italic>, <italic>F. indica</italic>, <italic>L. ocymifolia</italic>, <italic>L. martinicensis</italic>, <italic>P. kalachariensis</italic>, <italic>S. spinosa</italic> and&#x000a0;<italic>V. verrucosum</italic>) were considered to have antiproliferative effects as there was a significant difference between the treated cells and the cells only with <italic>P</italic>-value&#x02009;&#x0003c;&#x02009;0.0001. The extracts deemed effective included <italic>A. pungu</italic>, <italic>C. edulis</italic>, <italic>L. martinicensis</italic>, <italic>L. ocymifolia</italic>, <italic>L. martinicensis</italic> and <italic>V. verrucosum</italic> as they exhibited a reduction in cell viability by more than 50%<italic>.</italic> A concentration-dependant assay was conducted for the four methanolic plant extracts and the results are shown in Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>. The IC<sub>50</sub> values are shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.<fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>The effects of crude methanolic plant extracts on Jurkat T cell lines. Crude methanolic plant extracts were tested for their antiproliferative effect on Jurkat T cell line at a concentration of 250&#x000a0;&#x000b5;g/mL. Chlorambucil was used as a positive control at a concentration of 10&#x000a0;&#x003bc;g/mL. The negative control contained cells and RPMI media only. The cells were incubated with test solutions and cell viability was determined after 72&#x000a0;h. The values are for the mean&#x02009;&#x000b1;&#x02009;SD for <italic>n</italic>&#x02009;=&#x02009;3. All treatments were compared to cells only to determine the level of significance. The level of significance is denoted as follows: **** P&#x02009;&#x0003c;&#x02009;0.0001. <italic>A. pungu, C. edulis, F. indica</italic>, <italic>L. ocymifolia</italic>, <italic>L.martinicensis</italic>, <italic>P. kalachariensis</italic>, <italic>S. spinosa</italic> and <italic>V. verrucosum</italic>, significantly inhibited the proliferation of Jurkat T cell line and <italic>V. verrucosum</italic> had the greatest potency</p></caption><graphic xlink:href="12906_2025_4883_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig.&#x000a0;6</label><caption><p>Concentration-dependent effect of crude methanolic plant extracts on Jurkat T cell lines. The concentration dependent effect of crude methanolic plant extracts of <italic>A. pungu</italic>, <italic>C. edulis</italic>, <italic>L. ocymifolia</italic>, <italic>L. martinicensis</italic> and <italic>V</italic>. <italic>verrucosum</italic> were evaluated on Jurkat T cell lines. The cells were incubated with crude methanolic plant extracts at varying concentrations ranging from 0 to 250&#x000a0;&#x003bc;g/mL and cell viability was determined after 72&#x000a0;h. Chlorambucil was used as a positive control at a concentration of 1.25 to 10&#x000a0;&#x003bc;g/mL. The negative control contained cells and RPMI media only. The cell viability decreased with an increase in the concentration of the extract</p></caption><graphic xlink:href="12906_2025_4883_Fig6_HTML" id="MO6"/></fig></p></sec><sec id="Sec24"><title>The effect of plant extracts on HL60 cell lines</title><p id="Par41">The antiproliferative effect of thirteen crude methanolic extracts was also assessed on HL60 cell lines at a concentration of 250&#x000a0;&#x000b5;g/mL. The results are shown in Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref> and it was noted that nine plant extracts ( <italic>A. pungu</italic>, <italic>C. edulis</italic>, <italic>F. indica</italic>, <italic>L. ocymifolia</italic>, <italic>L. martinicensis</italic>, <italic>P. kalachariensis</italic>, <italic>S. cocculoides</italic>, <italic>S. spinosa</italic> and <italic>V. verrucosum</italic>) were considered potent as there was a significant difference between the treated cells and the negative control with P-value&#x02009;&#x0003c;&#x02009;0.0001. The extracts that reduced cell viability by 50% or more <italic>(A. pungu</italic>, <italic>C. edulis</italic>, <italic>L. ocymifolia</italic>, <italic>L. martinicensis</italic> and <italic>V. verucosum</italic>) were subjected to a concentration-dependent assay and the results are shown in Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref> and the IC<sub>50</sub> values were calculated and shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.<fig id="Fig7"><label>Fig.&#x000a0;7</label><caption><p>The effects of crude methanolic plant extracts on HL60 cell lines. Crude methanolic plant extracts were tested for their antiproliferative effect on HL60 cell line at a concentration of 250&#x000a0;&#x000b5;g/mL. Camptothecin was used as a positive control at a concentration of 10&#x000a0;&#x003bc;g/mL. The negative control contained cells and RPMI media only. The cells were incubated with test solutions and cell viability was determined after 72&#x000a0;h. The values are for the mean&#x02009;&#x000b1;&#x02009;SD for n&#x02009;=&#x02009;3. All treatments were compared to cells only to determine the level of significance. The level of significance is denoted as follows: **** P&#x02009;&#x0003c;&#x02009;0.0001. Plant extracts <italic>A. pungu</italic>, <italic>C. edulis</italic>, <italic>F. indica</italic>, <italic>L. ocymifolia</italic>, <italic>L. martinicensis</italic>, <italic>P. kalachariensis</italic>, <italic>S. cocculoides</italic>, <italic>S. spinosa</italic> and <italic>V. verrucosum</italic> significantly inhibited the proliferation of HL60 cells and <italic>V. verrucosum</italic> was the most active</p></caption><graphic xlink:href="12906_2025_4883_Fig7_HTML" id="MO7"/></fig><fig id="Fig8"><label>Fig.&#x000a0;8</label><caption><p>Concentration-dependent effect of crude methanolic plant extracts on HL60 cell lines. The concentration-dependent effect of crude methanolic plant extracts of <italic>A. pungu</italic>, <italic>C. edulis</italic>, <italic>L. ocymifolia</italic>, <italic>L. martinicensis</italic> and <italic>V</italic>. <italic>verrucosum</italic> were evaluated on HL60 cell lines. The cells were incubated with extracts at varying concentrations ranging from 0 to 250&#x000a0;&#x003bc;g/mL. Chlorambucil was used as a positive control at a concentration range of 1.25 to 10&#x000a0;&#x000b5;g/mL. The negative control contained cells and RPMI media only and cell viability was determined after 72&#x000a0;h. The cell viability decreased with an increase in the concentration of the extract</p></caption><graphic xlink:href="12906_2025_4883_Fig8_HTML" id="MO8"/></fig></p></sec></sec><sec id="Sec25"><title>Selectivity Index (SI) of potent methanolic plant extracts</title><p id="Par42">The SI values for Jurkat T and HL60 cell lines versus normal murine peritoneal cells were determined for the most potent plant extracts (<italic>A. pungu</italic> and <italic>V. verrucosum</italic>) and are shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.</p></sec><sec id="Sec26"><title>Phytochemical screening of methanolic plant extracts</title><p id="Par43">Thirteen plant extracts were screened for different classes of phytoconstituents and the results are shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and the frequency of phytochemical constituents are shown in Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>.
<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Phytochemical screening of thirteen medicinal plants used traditionally for the treatment of cancer in Zimbabwe</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Scientific name</th><th align="left">Flavonoids</th><th align="left">Alkaloids</th><th align="left">Saponins</th><th align="left">Phenolic compounds</th><th align="left">Steroids and phytosteroids</th><th align="left">Anthraquinone</th><th align="left">Terpenoids</th><th align="left">Quinones</th><th align="left">Tannins</th><th align="left">Coumarins</th></tr></thead><tbody><tr><td align="left"><italic>Agelanthus pungu</italic></td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td></tr><tr><td align="left"><italic>Carissa edulis</italic></td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td></tr><tr><td align="left"><italic>Dombeya rotundifolia</italic></td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td></tr><tr><td align="left"><italic>Flacourtia indica</italic></td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td></tr><tr><td align="left"><italic>Lannea discolor</italic></td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td></tr><tr><td align="left"><italic>Leonotis ocymifolia</italic></td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td></tr><tr><td align="left"><italic>Leucas maetinicensis</italic></td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td></tr><tr><td align="left"><italic>Plicosepalus kalachariensis</italic></td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td></tr><tr><td align="left"><italic>Pseudolachnostylis maprouneifolia</italic></td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td></tr><tr><td align="left"><italic>Solanum incanum</italic></td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">-</td></tr><tr><td align="left"><italic>Strychnos cocculoides</italic></td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td></tr><tr><td align="left"><italic>Strychnos spinosa</italic></td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td></tr><tr><td align="left"><italic>Viscum verrucosum</italic></td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">-</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td><td align="left">&#x02009;+&#x02009;</td></tr></tbody></table><table-wrap-foot><p>(&#x02009;+), present; (&#x02013;), absent</p></table-wrap-foot></table-wrap><fig id="Fig9"><label>Fig.&#x000a0;9</label><caption><p>Frequency of phytochemical constituents of the crude methanolic plant extracts. Among the 13 methanolic plant extracts screened, 10 contained alkaloids, 9 contained flavonoids, and 9 had saponins. Alkaloids, flavonoids and saponins were the most common phytochemical classes present in the plant extracts</p></caption><graphic xlink:href="12906_2025_4883_Fig9_HTML" id="MO9"/></fig></p></sec></sec><sec id="Sec27"><title>Discussion</title><p id="Par44">Plants are a rich source of natural compounds and the importance of such compounds has been proven since time immemorial [<xref ref-type="bibr" rid="CR23">23</xref>]. Cancer has become a cause of morbidity and mortality across the globe, this is because there has been an increase in incidences of drug-resistant cancer and some cancer treatments have severe side effects [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], hence, there is a need to search for new anti-cancer drugs with little or no side effects. An ideal anti-cancer drug should be able to destroy cancer cells while leaving the normal cells undamaged [<xref ref-type="bibr" rid="CR26">26</xref>]. Phytochemical compounds have offered promising alternatives to synthetic drugs and these significantly contributed to cancer treatment [<xref ref-type="bibr" rid="CR27">27</xref>]. Hence, the current study evaluated the antiproliferative and cytotoxic effects of medicinal plants used traditionally in Zimbabwe for the treatment and management of cancer.</p><sec id="Sec28"><title>The cytotoxic effects of methanolic plant extracts on normal cells</title><sec id="Sec29"><title>The effects of plant extracts on normal murine peritoneal cells</title><p id="Par45">Cytotoxicity is an important factor in the search for novel anticancer agents from plants. It is the toxic effect of a compound that leads to cell death [<xref ref-type="bibr" rid="CR28">28</xref>]. By evaluating cytotoxicity on normal murine peritoneal cells, the current study aimed at assessing the potentially toxic effects of the extracts.</p><p id="Par46">Mistletoes <italic>A. pungu</italic> and <italic>V. verrucosum</italic> methanolic extracts were the most cytotoxic on normal murine peritoneal cells. Currently, there is no available literature on the cytotoxicity of these mistletoes on normal cell lines. However, mistletoes in the same families (Santaliaceae and Loranthaceae) have been studied and found to contain several cytotoxic compounds [<xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>]. It has been found that compounds from <italic>Viscum coloratum</italic> (Kom.) Nakai and <italic>Viscum album</italic> L. were cytotoxic to normal cell lines [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Alkaloids and phenolic compounds were identified as primary biological active components in these mistletoe species [<xref ref-type="bibr" rid="CR34">34</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>]. Phytochemical screening of <italic>A. pungu</italic> and <italic>V. verrucosum</italic> in this study confirmed that both mistletoes contain alkaloids and phenolic compounds. This suggested that <italic>A. pungu</italic> and <italic>V. verrucosum</italic> might have similar compounds to those of mistletoes in the same family that have been studied. However, further research is required to determine the compounds responsible for the cytotoxic activity in <italic>A. pungu</italic> and <italic>V. verrucosum</italic>.</p></sec><sec id="Sec30"><title>The effect of plant extracts on sheep erythrocytes</title><p id="Par47">Haemolysis assay on sheep erythrocytes was used in this study to evaluate the effect of cytotoxic extracts on membrane integrity [<xref ref-type="bibr" rid="CR37">37</xref>]. Haemolysis is the destruction of red blood cells resulting from the lysis of the membrane lipid bilayer [<xref ref-type="bibr" rid="CR38">38</xref>]. Plant extracts may destabilise the membrane of red blood cells and this in turn can cause haemolysis [<xref ref-type="bibr" rid="CR39">39</xref>]. The results show that haemolytic activity was concentration-dependent, wherein higher concentrations of plant extract correlated with increased haemolytic activity. The results are in agreement with previous studies by Zejli et al. [<xref ref-type="bibr" rid="CR40">40</xref>] suggesting that haemolytic activity increases with extract concentration, as postulated by Fick&#x02019;s Law which states that diffusion flux from a membrane is proportional to the concentration difference of both sides [<xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par48">Plant extracts were considered to be haemolytic if the percentage of haemolysis was greater than 30% as a study by Khursheed et al. [<xref ref-type="bibr" rid="CR42">42</xref>]. <italic>A. pungu</italic> and <italic>S. spinosa</italic> extracts exhibited low haemolytic activity of less than 30% at all concentrations. <italic>F. indica</italic> and <italic>V. verrucosum</italic> had haemolytic activity above 30% at the highest concentration (250&#x000a0;&#x000b5;g/mL), with <italic>V. verrucosum</italic> additionally exhibiting haemolytic effects at 125&#x000a0;&#x000b5;g/mL. Studies by Kim et al. and Podalak et al., have shown that the haemolytic activity of plant extracts can be attributed to the presence of phytochemicals such as saponins [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. In the current study, phytochemical screening revealed the presence of saponins in <italic>F. indica</italic> and <italic>V. verrucosum.</italic> As a result, saponins are likely to be responsible for the haemolytic activity observed. Several studies indicate that saponins can attach to erythrocyte membranes and destabilise them, resulting in haemolysis [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. As the concentration of saponins increases, there is a concurrent increase in haemolytic activity [<xref ref-type="bibr" rid="CR45">45</xref>]. This could provide additional rationale for the higher degree of haemolysis observed at the highest concentration of 250&#x000a0;&#x003bc;g/mL as compared to lower concentrations.</p></sec><sec id="Sec31"><title>The effect of reduced-glutathione (GSH) on the activity of cytotoxic extracts on normal murine peritoneal cells</title><p id="Par49">It is common practice for cancer patients to use dietary supplements with antioxidants during or after conventional cancer treatments to enhance the benefits of the treatment and prevent side effects [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. The use of antioxidants during chemotherapy has been condemned as it is believed to interfere with the efficacy of the drug [<xref ref-type="bibr" rid="CR9">9</xref>]. However, some practitioners use antioxidant supplements so that patients can tolerate higher effective doses of chemotherapy [<xref ref-type="bibr" rid="CR48">48</xref>]. Antioxidants are viewed as a safe means of protecting cells and tissues from damage caused by free radicals thus preventing the onset of cancer and side effects of chemotherapy [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>].</p><p id="Par50">Reduced-glutathione (GSH) is a naturally occurring antioxidant that plays a critical role in defence, cellular process regulation, and nutrient metabolism [<xref ref-type="bibr" rid="CR50">50</xref>]. The effect of GSH was investigated on <italic>A. pungu</italic> and <italic>V. verrucosum</italic> extracts which reduced cell viability of normal murine peritoneal cells by more than 50%. Based on the classification by L&#x000f3;pez Villarreal et al., [<xref ref-type="bibr" rid="CR51">51</xref>] these extracts were categorised as moderately toxic. The addition of GSH to the extracts of <italic>A. pungu</italic> and <italic>V. verrucosum</italic> led to an increase in cell viability. This finding aligns with previous by Singh et al., studies suggesting antioxidants mitigate drug-induced cytotoxic effects [<xref ref-type="bibr" rid="CR48">48</xref>]. Furthermore, research has demonstrated a heightened therapeutic response to drugs when accompanied by antioxidant supplementation [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. However, since these were in vitro studies, further studies are necessary to confirm these findings and evaluate their potential therapeutic implications.</p></sec><sec id="Sec32"><title>The antiproliferative effect of plant extracts on cancer cell lines</title><p id="Par51">Antiproliferative assays are widely used to assess the effectiveness of potential anticancer agents [<xref ref-type="bibr" rid="CR53">53</xref>], by measuring their ability to inhibit cancer cell growth. These assays provide valuable insights into the therapeutic potential of test compounds, which can help slow or even halt disease progression [<xref ref-type="bibr" rid="CR54">54</xref>]. In this study, antiproliferation assays were conducted on leukaemia cell lines specifically Jurkat T and HL60 cell lines to evaluate the effectiveness of methanolic plant extracts. Leukaemia was chosen as a target due to the high rate of leukaemia cases in Zimbabwe [<xref ref-type="bibr" rid="CR55">55</xref>] and the fact that it is the leading cause of death for all haematological malignancies worldwide [<xref ref-type="bibr" rid="CR56">56</xref>].</p></sec><sec id="Sec33"><title>The effect of plant extracts on Jurkat T and HL60 cell lines</title><p id="Par52">The plant species <italic>A. pungu, C. edulis, F. indica, L. ocymifolia, L. martinicensis, P. kalachariensis, S. cocculoides S. spinosa and V. verrucosum</italic> significantly inhibited the proliferation of both leukaemia (HL60 and Jurkat T) cell lines, as confirmed by statistical analysis (p&#x02009;&#x0003c;&#x02009;0.0001). The extract of <italic>S. cocculoides</italic> extracts had a significant antiproliferative effect on the HL60 cell line, as supported by statistical analysis (p&#x02009;&#x0003c;&#x02009;0.0001). <italic>Strychnos</italic> species (Loganiaceae) are considered among the most renowned plants for their health-promoting properties [<xref ref-type="bibr" rid="CR57">57</xref>]. However, to the best of our knowledge, the antiproliferative effects of <italic>S. cocculoides</italic> have never been reported before.</p><p id="Par53">It was noted that <italic>S. cocculoides</italic> had significant antiproliferative activity on HL60 than on Jurkart T cell lines. The difference in the antiproliferative effects of <italic>S. cocculoides</italic> on HL60 and Jurkat T cell lines could be attributed to variations in the genetic makeup and susceptibility of the cells to the compounds present in the plant [<xref ref-type="bibr" rid="CR58">58</xref>]. Different cell lines can exhibit diverse responses to the same treatment due to variations in their molecular characteristics and underlying mechanisms of proliferation [<xref ref-type="bibr" rid="CR59">59</xref>]. Additionally, the use of different methods to determine cell viability, such as the SRB assay for HL60 cell lines and the trypan blue exclusion method for Jurkat T cell lines, could have contributed to the observed difference in antiproliferative effects. One method may be more sensitive than the other, leading to variations in the reported percentage viability between the two cell lines.</p><p id="Par54">The results revealed that the activity of methanolic plant extracts increased with an increase in the concentration of extract, which is consistent with previous studies by Gul et al. and Pieme et al. [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. This suggests that higher concentrations of these extracts may have a stronger antiproliferative effect on both cell lines, HL60 and Jurkat T. Extracts of <italic>C</italic>. <italic>edulis</italic>, and <italic>L</italic>. <italic>martinicensis</italic> have been used traditionally for the treatment of cancer [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Research on <italic>C. edulis</italic> has proved that it has antitumor activity [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR64">64</xref>] and its characterisation led to the isolation of lupeol [<xref ref-type="bibr" rid="CR65">65</xref>], a compound with proven anti-cancer properties [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. Preliminary studies by Matata et al., show that <italic>L</italic>. <italic>martinicensis</italic> extract might have some anti-cancer properties [<xref ref-type="bibr" rid="CR68">68</xref>] and this is in line with the results that were obtained in this study. However, to our knowledge, no studies have reported the antiproliferative effects of <italic>A. pungu</italic>, <italic>L. ocymifolia</italic> and <italic>V. verrucosum</italic> on HL60 and Jurkat T cell lines.</p><p id="Par55">In the present study <italic>V</italic>. <italic>verrucosum</italic> was the most potent extract with IC<sub>50</sub> values of 33 and 34&#x000a0;&#x000b5;g/mL on Jurkat T and HL 60 cell lines respectively. Based on the IC<sub>50</sub> values, this extract shows potential for further development as a source of chemotherapeutic compounds. This potential aligns with the criteria set by the American Cancer Institute [<xref ref-type="bibr" rid="CR69">69</xref>]. <italic>Viscum verrucosum</italic> is a type of mistletoe and traditionally a wide range of mistletoe species have been used in the treatment of several ailments, including cancer [<xref ref-type="bibr" rid="CR70">70</xref>]. Mistletoes, including <italic>V. album</italic> from the Santalaceae family, have been identified as promising alternative therapies for treating various types of cancer [<xref ref-type="bibr" rid="CR31">31</xref>]. Numerous studies on <italic>V. album</italic> have demonstrated that its compounds possess antiproliferative effects [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>], and it is likely that <italic>V. verrucosum</italic>, also from the same family, may exhibit similar bioactive compounds.</p></sec><sec id="Sec34"><title>Selectivity Index (SI) of potent plant extract</title><p id="Par56">Chemotherapy is the most widely used treatment for leukaemia, involving the use of drugs to slow the growth or destroy cancerous cells [<xref ref-type="bibr" rid="CR8">8</xref>]. Despite its wide use, chemotherapy is known to have side effects since it damages both normal and cancerous cells, thus limiting its clinical application [<xref ref-type="bibr" rid="CR8">8</xref>]. In the search for novel chemotherapeutic compounds from plants, it is important to evaluate the selectivity of plant extracts as this will indicate compound toxicity to normal cells [<xref ref-type="bibr" rid="CR73">73</xref>]. In the present study, the effect of methanolic plant extracts was evaluated on leukaemia cell lines (Jurkat T and HL60) and normal animal cells.</p><p id="Par57">To identify extracts that are both active on cancer cell lines and safe for normal cells, Selectivity Index (SI) values were calculated for potent extracts. An SI value of less than 1 meant that the plant extract was non-selective (toxic), between 1 and 10 the extract was weakly selective and greater than 10 meant the plant was safe (non-toxic), leading to better outcomes and fewer side effects for patients [<xref ref-type="bibr" rid="CR20">20</xref>]. The SI values of <italic>A. pungu</italic> and <italic>V. verrucosum</italic> ranged between 1 and 10, indicating that these plant species are weakly selective, meaning they are slightly toxic to normal cells. Therefore, further research is needed to determine their safety profile.</p></sec></sec><sec id="Sec35"><title>Phytochemical Screening of plant extracts</title><p id="Par58">Phytochemicals are responsible for the biological activities of plant extracts [<xref ref-type="bibr" rid="CR74">74</xref>]. Results show that plant methanolic extracts have several phytochemical classes with alkaloids, flavonoids and saponins being the most abundant. Alkaloids are the most common phytochemicals and they exhibit a wide range of pharmacological activities including anti-cancer properties [<xref ref-type="bibr" rid="CR75">75</xref>]. Hence, they have been used in the development of anticancer drugs such as vincristine, vinblastine and taxol [<xref ref-type="bibr" rid="CR76">76</xref>]. Therefore, the results obtained are in line with literature findings that alkaloids are the most abundant phytochemicals in plant extracts [<xref ref-type="bibr" rid="CR75">75</xref>].</p><p id="Par59">Flavonoids have recently gained importance due to their anticancer properties [<xref ref-type="bibr" rid="CR77">77</xref>]; they have shown substantial potential as cytotoxic agents [<xref ref-type="bibr" rid="CR36">36</xref>]. In the current study, a large number of methanolic plant extracts contained flavonoids and in the literature, this class of compounds has been reported to have beneficial effects on treating various diseases including cancer [<xref ref-type="bibr" rid="CR78">78</xref>]. Plant-derived flavonoids like apigenin have proven anticancer properties with low toxicity to normal cells making them ideal anti-cancer drug candidates [<xref ref-type="bibr" rid="CR79">79</xref>].</p><p id="Par60">Saponins have shown potential in cancer treatment due to their ability to inhibit tumour cell growth, induce apoptosis, and suppress angiogenesis [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. Their anticancer properties have been linked to structural diversity, making them promising candidates for novel anticancer therapies. Saponin-based anticancer drugs are currently unavailable, despite extensive research and significant anticancer effects [<xref ref-type="bibr" rid="CR80">80</xref>]. This could be attributed to their inherent toxicities and complex chemical structures, which make it difficult to synthesise and purify them [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>].</p></sec></sec><sec id="Sec36"><title>Conclusion</title><p id="Par61">The evaluation of antiproliferative, cytotoxic and phytochemical properties of Zimbabwean medicinal plants used in cancer treatment has provided valuable insight into their therapeutic effect. Plants that showed potential antiproliferative effects included <italic>A</italic>. <italic>pungu</italic>, <italic>C</italic>. <italic>edulis</italic>, <italic>L</italic>. <italic>ocymifolia</italic>, <italic>L</italic>. <italic>martinicensis</italic> and <italic>V</italic>. <italic>verrucosum</italic> on Jurkat T and HL60 cell lines. Mistletoe <italic>V</italic>. <italic>verrucosum</italic> was found to be the most potent with the lowest IC<sub>50</sub> values of 33 and 34&#x000a0;&#x000b5;g/mL on Jurkat T and HL60 respectively. However, <italic>V. verrucosum</italic> displayed weak selectivity, suggesting that it is mildly toxic to normal cells as it had an IC<sub>50</sub> of 134&#x000a0;&#x000b5;g/mL on normal murine peritoneal cells. Additionally the <italic>V. verrucosum</italic> extract caused destabilisation of the erythrocytes sheep membrane at 125 and 250&#x000a0;&#x000b5;g/mL. The addition of GSH appeared to have a protective effect on cells, potentially counteracting the cytotoxic effect of plant extracts on normal murine peritoneal cells. The study confirmed the presence of medicinally significant phytochemical classes such as alkaloids, flavonoids, terpenoids, quinones and saponins in plant extracts. Therefore, these findings emphasize the need for further research to evaluate the mechanism of action and the activity of extracts on other cancer cell lines. Additionally, investigating the phytochemical composition of potent methanolic plant extracts is essential.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>FBS</term><def><p id="Par5">Foetal Bovine Serum</p></def></def-item><def-item><term>RPMI</term><def><p id="Par6">Roswell Park Memorial Institute</p></def></def-item><def-item><term>GSH</term><def><p id="Par7">Reduced&#x02014;Glutathione</p></def></def-item><def-item><term>PNS</term><def><p id="Par8">Penicillin Streptomycin Neomycin</p></def></def-item><def-item><term>HBSS</term><def><p id="Par9">Hanks&#x02019; Balanced Salt Solution</p></def></def-item><def-item><term>DMSO</term><def><p id="Par10">Dimethyl sulfoxide</p></def></def-item><def-item><term>FCS</term><def><p id="Par11">Foetal Calf serum</p></def></def-item><def-item><term>TCA</term><def><p id="Par12">Trichloroacetic Acid</p></def></def-item><def-item><term>SRB</term><def><p id="Par13">Sulforhodamine B</p></def></def-item><def-item><term>SI</term><def><p id="Par14">Selectivity Index</p></def></def-item><def-item><term>IC<sub>50</sub></term><def><p id="Par15">Half-maximal inhibitory concentration</p></def></def-item><def-item><term>WHO</term><def><p id="Par16">World Health Organisation</p></def></def-item><def-item><term>RDC</term><def><p id="Par17">Rural District Council</p></def></def-item><def-item><term>ECACC</term><def><p id="Par18">European Collection of Authenticated Cell Culture</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors are grateful to the National University of Science and Technology (NUST) Research Board for funding the research, relevant Rural District Councils where plant samples were collected and the Biomolecular Interaction Analysis Laboratory at the University of Zimbabwe for allowing us to carry out tissue culture experiments.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>S.M.1 conducted all the in vitro experimental studies with the assistance of S.S.2 and S.M.2. All authors read and approved the final manuscript. S.S.1 and Y.N directed the study. S.M.1 wrote the first draft. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research work was funded by the National University of Science and Technology (NUST)</p><p>Research Board grant numbers RB/56/16, 57/16, and 19/17. The funders had no role in the design of the study design, data collection, analysis, interpretation of data, and writing of the manuscript.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data are included within the manuscript.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par62">The study was approved by the Faculty Higher Degrees Committee during its 318<sup>th</sup> meeting in November 2017 at the National University of Science and Technology (NUST), Zimbabwe. This approval was granted in the form of a written project proposal discussed in the board meeting. The NUST Institutional Review Board also approved the study, assigning it approval number NUST/IRB/2022/48. Permission to collect plant species was obtained from the relevant Rural District Councils and Community Leaders.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par63">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par64">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Hofmarcher T, Manzano Garc&#x000ed;a A, Wilking N &#x00026; Lindgren P. The Disease Burden and Economic Burden of Cancer in 9 Countries in the Middle East and Africa. Value Health Reg<italic>. </italic>2023;37:81&#x02013;87.</mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferlay</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cancer statistics for the year 2020: An overview</article-title><source>Int J Cancer</source><year>2021</year><pub-id pub-id-type="doi">10.1002/ijc.33588</pub-id><?supplied-pmid 34460109?><pub-id pub-id-type="pmid">34460109</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Ferlay J, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021. 10.1002/ijc.33588.<pub-id pub-id-type="pmid">34460109</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Stefan</surname><given-names>DC</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name></person-group><article-title>Addressing cancer care in low- to middle-income countries: a call for sustainable innovations and impactful research</article-title><source>BMC Cancer</source><year>2023</year><volume>23</volume><fpage>756</fpage><pub-id pub-id-type="doi">10.1186/s12885-023-11272-9</pub-id><?supplied-pmid 37582762?><pub-id pub-id-type="pmid">37582762</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Stefan DC, Tang S. Addressing cancer care in low- to middle-income countries: a call for sustainable innovations and impactful research. BMC Cancer. 2023;23:756.<pub-id pub-id-type="pmid">37582762</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>H</given-names></name><etal/></person-group><article-title>Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries</article-title><source>CA Cancer J Clin</source><year>2021</year><volume>71</volume><fpage>209</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.3322/caac.21660</pub-id><?supplied-pmid 33538338?><pub-id pub-id-type="pmid">33538338</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209&#x02013;49.<pub-id pub-id-type="pmid">33538338</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Parkin</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Changes in the Incidence of Cancer in Bulawayo, Zimbabwe over a 50-Year Period</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2021</year><volume>30</volume><fpage>867</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-20-0669</pub-id><?supplied-pmid 33619023?><pub-id pub-id-type="pmid">33619023</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Parkin DM, et al. Changes in the Incidence of Cancer in Bulawayo, Zimbabwe over a 50-Year Period. Cancer Epidemiol Biomarkers Prev. 2021;30:867&#x02013;73.<pub-id pub-id-type="pmid">33619023</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Hunger, S. P., Teachey, D. T., Grupp, S. &#x00026; Aplenc, R. 93 - Childhood Leukemia. in <italic>Abeloff&#x02019;s Clinical Oncology (Sixth Edition)</italic> (eds. Niederhuber, J. E., Armitage, J. O., Kastan, M. B., Doroshow, J. H. &#x00026; Tepper, J. E.) 1748&#x02013;1764.e4 (Elsevier, Philadelphia, 2020). 10.1016/B978-0-323-47674-4.00093-1.</mixed-citation></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment</article-title><source>MedComm</source><year>2021</year><volume>2</volume><fpage>315</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1002/mco2.55</pub-id><?supplied-pmid 34766149?><pub-id pub-id-type="pmid">34766149</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Liu Y, et al. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment. MedComm. 2021;2:315&#x02013;40.<pub-id pub-id-type="pmid">34766149</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>U</given-names></name><etal/></person-group><article-title>Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics</article-title><source>Genes Dis</source><year>2022</year><volume>10</volume><fpage>1367</fpage><lpage>1401</lpage><pub-id pub-id-type="doi">10.1016/j.gendis.2022.02.007</pub-id><?supplied-pmid 37397557?><pub-id pub-id-type="pmid">37397557</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Anand U, et al. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2022;10:1367&#x02013;401.<pub-id pub-id-type="pmid">37397557</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Wieland</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Risks and benefits of antioxidant dietary supplement use during cancer treatment: protocol for a scoping review</article-title><source>BMJ Open</source><year>2021</year><volume>11</volume><fpage>e047200</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2020-047200</pub-id><?supplied-pmid 33849858?><pub-id pub-id-type="pmid">33849858</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Wieland LS, et al. Risks and benefits of antioxidant dietary supplement use during cancer treatment: protocol for a scoping review. BMJ Open. 2021;11:e047200.<pub-id pub-id-type="pmid">33849858</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Debela</surname><given-names>DT</given-names></name><etal/></person-group><article-title>New approaches and procedures for cancer treatment: Current perspectives</article-title><source>SAGE Open Med</source><year>2021</year><volume>9</volume><fpage>20503121211034366</fpage><pub-id pub-id-type="doi">10.1177/20503121211034366</pub-id><?supplied-pmid 34408877?><pub-id pub-id-type="pmid">34408877</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Debela DT, et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med. 2021;9:20503121211034370.<pub-id pub-id-type="pmid">34408877</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">WHO. African Traditional Medicine Day 2022. <italic>WHO | Regional Office for Africa</italic><ext-link ext-link-type="uri" xlink:href="https://www.afro.who.int/regional-director/speeches-messages/african-traditional-medicine-day-2022">https://www.afro.who.int/regional-director/speeches-messages/african-traditional-medicine-day-2022</ext-link> (2022).</mixed-citation></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>J</given-names></name><etal/></person-group><article-title>Plant-derived anticancer agents: A green anticancer approach</article-title><source>Asian Pac J Trop Biomed</source><year>2017</year><volume>7</volume><fpage>1129</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1016/j.apjtb.2017.10.016</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Iqbal J, et al. Plant-derived anticancer agents: A green anticancer approach. Asian Pac J Trop Biomed. 2017;7:1129&#x02013;50.</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Esmeeta</surname><given-names>A</given-names></name><etal/></person-group><article-title>Plant-derived bioactive compounds in colon cancer treatment: An updated review</article-title><source>Biomed Pharmacother</source><year>2022</year><volume>153</volume><fpage>113384</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2022.113384</pub-id><?supplied-pmid 35820317?><pub-id pub-id-type="pmid">35820317</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Esmeeta A, et al. Plant-derived bioactive compounds in colon cancer treatment: An updated review. Biomed Pharmacother. 2022;153:113384.<pub-id pub-id-type="pmid">35820317</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Mlilo</surname><given-names>S</given-names></name><name><surname>Sibanda</surname><given-names>S</given-names></name></person-group><article-title>An ethnobotanical survey of the medicinal plants used in the treatment of cancer in some parts of Matebeleland</article-title><source>Zimbabwe South Afr J Bot</source><year>2022</year><volume>146</volume><fpage>401</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2021.11.022</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Mlilo S, Sibanda S. An ethnobotanical survey of the medicinal plants used in the treatment of cancer in some parts of Matebeleland. Zimbabwe South Afr J Bot. 2022;146:401&#x02013;8.</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Ray A, Dittel B. Isolation of Mouse Peritoneal Cavity Cells. J Vis Exp JoVE. 2010;35:1488.</mixed-citation></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Mapfunde</surname><given-names>S</given-names></name><name><surname>Sithole</surname><given-names>S</given-names></name><name><surname>Mukanganyama</surname><given-names>S</given-names></name></person-group><article-title>In vitro toxicity determination of antifungal constituents from Combretum zeyheri</article-title><source>BMC Complement Altern Med</source><year>2016</year><volume>16</volume><fpage>162</fpage><pub-id pub-id-type="doi">10.1186/s12906-016-1150-9</pub-id><?supplied-pmid 27251466?><pub-id pub-id-type="pmid">27251466</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Mapfunde S, Sithole S, Mukanganyama S. In vitro toxicity determination of antifungal constituents from Combretum zeyheri. BMC Complement Altern Med. 2016;16:162.<pub-id pub-id-type="pmid">27251466</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Machingauta A. et al. Evaluation of the antiproliferative effect of &#x003b2;-sitosterol isolated from Combretum platypetalum Welw. ex M.A. Lawson (Combretaceae) on Jurkat-T cells and protection by glutathione. Adv Tradit Med<italic>.</italic>&#x000a0;2022;22:865&#x02013;873.</mixed-citation></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Skehan</surname><given-names>P</given-names></name><etal/></person-group><article-title>New colorimetric cytotoxicity assay for anticancer-drug screening</article-title><source>J Natl Cancer Inst</source><year>1990</year><volume>82</volume><fpage>1107</fpage><lpage>1112</lpage><pub-id pub-id-type="doi">10.1093/jnci/82.13.1107</pub-id><?supplied-pmid 2359136?><pub-id pub-id-type="pmid">2359136</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Skehan P, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82:1107&#x02013;12.<pub-id pub-id-type="pmid">2359136</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">McGaw, L. J., Elgorashi, E. E. &#x00026; Eloff, J. N. 8 - Cytotoxicity of African Medicinal Plants Against Normal Animal and Human Cells. in <italic>Toxicological Survey of African Medicinal Plants</italic> (ed. Kuete, V.) 181&#x02013;233 (Elsevier, 2014). 10.1016/B978-0-12-800018-2.00008-X.</mixed-citation></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Ogbole</surname><given-names>OO</given-names></name><name><surname>Segun</surname><given-names>PA</given-names></name><name><surname>Adeniji</surname><given-names>AJ</given-names></name></person-group><article-title>In vitro cytotoxic activity of medicinal plants from Nigeria ethnomedicine on Rhabdomyosarcoma cancer cell line and HPLC analysis of active extracts</article-title><source>BMC Complement Altern Med</source><year>2017</year><volume>17</volume><fpage>494</fpage><pub-id pub-id-type="doi">10.1186/s12906-017-2005-8</pub-id><?supplied-pmid 29166892?><pub-id pub-id-type="pmid">29166892</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Ogbole OO, Segun PA, Adeniji AJ. In vitro cytotoxic activity of medicinal plants from Nigeria ethnomedicine on Rhabdomyosarcoma cancer cell line and HPLC analysis of active extracts. BMC Complement Altern Med. 2017;17:494.<pub-id pub-id-type="pmid">29166892</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Guevara BQ. UST Research Center for the Natural Sciences. <italic>A Guidebook to Plant Screening: Phytochemical and Biological</italic>. (University of Santo Tomas Publishing House, Manila, 2005:101&#x02013;30.</mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Harborne AJ. <italic>Phytochemical Methods A Guide to Modern Techniques of Plant Analysis</italic>. (Springer Science &#x00026; Business Media). 1998. p. 1&#x02013;32.</mixed-citation></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kaur</surname><given-names>S</given-names></name><name><surname>Sangwan</surname><given-names>PL</given-names></name><name><surname>Tasduq</surname><given-names>SA</given-names></name></person-group><article-title>Therapeutic and cosmeceutical role of glycosylated natural products in dermatology</article-title><source>Phytother Res</source><year>2023</year><volume>37</volume><fpage>1574</fpage><lpage>1589</lpage><pub-id pub-id-type="doi">10.1002/ptr.7752</pub-id><?supplied-pmid 36809543?><pub-id pub-id-type="pmid">36809543</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Kumar A, Kaur S, Sangwan PL, Tasduq SA. Therapeutic and cosmeceutical role of glycosylated natural products in dermatology. Phytother Res. 2023;37:1574&#x02013;89.<pub-id pub-id-type="pmid">36809543</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Avner</surname><given-names>BS</given-names></name><name><surname>Fialho</surname><given-names>AM</given-names></name><name><surname>Chakrabarty</surname><given-names>AM</given-names></name></person-group><article-title>Overcoming drug resistance in multi-drug resistant cancers and microorganisms: A conceptual framework</article-title><source>Bioengineered</source><year>2012</year><volume>3</volume><fpage>262</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.4161/bioe.21130</pub-id><?supplied-pmid 22750915?><pub-id pub-id-type="pmid">22750915</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Avner BS, Fialho AM, Chakrabarty AM. Overcoming drug resistance in multi-drug resistant cancers and microorganisms: A conceptual framework. Bioengineered. 2012;3:262&#x02013;70.<pub-id pub-id-type="pmid">22750915</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Talib</surname><given-names>WH</given-names></name><name><surname>Alsayed</surname><given-names>AR</given-names></name><name><surname>Barakat</surname><given-names>M</given-names></name><name><surname>Abu-Taha</surname><given-names>MI</given-names></name><name><surname>Mahmod</surname><given-names>AI</given-names></name></person-group><article-title>Targeting Drug Chemo-Resistance in Cancer Using Natural Products</article-title><source>Biomedicines</source><year>2021</year><volume>9</volume><fpage>1353</fpage><pub-id pub-id-type="doi">10.3390/biomedicines9101353</pub-id><?supplied-pmid 34680470?><pub-id pub-id-type="pmid">34680470</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Talib WH, Alsayed AR, Barakat M, Abu-Taha MI, Mahmod AI. Targeting Drug Chemo-Resistance in Cancer Using Natural Products. Biomedicines. 2021;9:1353.<pub-id pub-id-type="pmid">34680470</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Feola</surname><given-names>S</given-names></name><name><surname>Russo</surname><given-names>S</given-names></name><name><surname>Yl&#x000f6;sm&#x000e4;ki</surname><given-names>E</given-names></name><name><surname>Cerullo</surname><given-names>V</given-names></name></person-group><article-title>Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment</article-title><source>Pharmacol Ther</source><year>2022</year><volume>236</volume><fpage>108103</fpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2021.108103</pub-id><?supplied-pmid 34954301?><pub-id pub-id-type="pmid">34954301</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Feola S, Russo S, Yl&#x000f6;sm&#x000e4;ki E, Cerullo V. Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment. Pharmacol Ther. 2022;236:108103.<pub-id pub-id-type="pmid">34954301</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>J-J</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name></person-group><article-title>Natural Products in Cancer Therapy: Past</article-title><source>Present and Future Nat Prod Bioprospecting</source><year>2021</year><volume>11</volume><fpage>5</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1007/s13659-020-00293-7</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Huang M, Lu J-J, Ding J. Natural Products in Cancer Therapy: Past. Present and Future Nat Prod Bioprospecting. 2021;11:5&#x02013;13.</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Shaik</surname><given-names>BB</given-names></name><name><surname>Katari</surname><given-names>NK</given-names></name><name><surname>Jonnalagadda</surname><given-names>SB</given-names></name></person-group><article-title>Role of Natural Products in Developing Novel Anticancer Agents: A Perspective</article-title><source>Chem Biodivers</source><year>2022</year><volume>19</volume><fpage>e202200535</fpage><pub-id pub-id-type="doi">10.1002/cbdv.202200535</pub-id><?supplied-pmid 36347633?><pub-id pub-id-type="pmid">36347633</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Shaik BB, Katari NK, Jonnalagadda SB. Role of Natural Products in Developing Novel Anticancer Agents: A Perspective. Chem Biodivers. 2022;19:e202200535.<pub-id pub-id-type="pmid">36347633</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">Elsyana V, Bintang M &#x00026; Priosoeryanto BP. Cytotoxicity and Antiproliferative Activity Assay of Clove Mistletoe (<italic>Dendrophthoe pentandra</italic> (L.) Miq.) Leaves Extracts. Adv Pharmacol Pharm. Sci.&#x000a0;2016;2016:e3242698.</mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Ochocka JR, &#x00026; Piotrowski A. Biologically active compounds from European mistletoe (Viscum album L.)1. Can J Plant Pathol<italic>.</italic>&#x000a0;2002;24:21&#x02013;28.</mixed-citation></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Szurpnicka</surname><given-names>A</given-names></name><name><surname>Kowalczuk</surname><given-names>A</given-names></name><name><surname>Szterk</surname><given-names>A</given-names></name></person-group><article-title>Biological activity of mistletoe: in vitro and in vivo studies and mechanisms of action</article-title><source>Arch Pharm Res</source><year>2020</year><volume>43</volume><fpage>593</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1007/s12272-020-01247-w</pub-id><?supplied-pmid 32621089?><pub-id pub-id-type="pmid">32621089</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Szurpnicka A, Kowalczuk A, Szterk A. Biological activity of mistletoe: in vitro and in vivo studies and mechanisms of action. Arch Pharm Res. 2020;43:593&#x02013;629.<pub-id pub-id-type="pmid">32621089</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>J</given-names></name><etal/></person-group><article-title>Novel drug isolated from mistletoe (1E,4E)-1,7-bis(4-hydroxyphenyl)hepta-1,4-dien-3-one for potential treatment of various cancers: synthesis, pharmacokinetics and pharmacodynamics</article-title><source>RSC Adv</source><year>2020</year><volume>10</volume><fpage>27794</fpage><lpage>27804</lpage><pub-id pub-id-type="doi">10.1039/D0RA03674A</pub-id><?supplied-pmid 35516963?><pub-id pub-id-type="pmid">35516963</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Hong J, et al. Novel drug isolated from mistletoe (1E,4E)-1,7-bis(4-hydroxyphenyl)hepta-1,4-dien-3-one for potential treatment of various cancers: synthesis, pharmacokinetics and pharmacodynamics. RSC Adv. 2020;10:27794&#x02013;804.<pub-id pub-id-type="pmid">35516963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J-H</given-names></name><name><surname>Hyun</surname><given-names>C-K</given-names></name><name><surname>Shin</surname><given-names>H-K</given-names></name></person-group><article-title>Cytotoxic effects of the components in heat-treated mistletoe (<italic>Viscum album</italic>)</article-title><source>Cancer Lett</source><year>1999</year><volume>139</volume><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/S0304-3835(99)00043-9</pub-id><?supplied-pmid 10395180?><pub-id pub-id-type="pmid">10395180</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Park J-H, Hyun C-K, Shin H-K. Cytotoxic effects of the components in heat-treated mistletoe (<italic>Viscum album</italic>). Cancer Lett. 1999;139:207&#x02013;13.<pub-id pub-id-type="pmid">10395180</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Melo MN, de O. et al<italic>.</italic> A Scoping Review of Genus Viscum: Biological and Chemical Aspects of Alcoholic Extracts. Plants.&#x000a0;2023;12;1811.</mixed-citation></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>C</given-names></name><etal/></person-group><article-title>Exploring the resources of the genus <italic>Viscum</italic> for potential therapeutic applications</article-title><source>J Ethnopharmacol</source><year>2021</year><volume>277</volume><fpage>114233</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2021.114233</pub-id><?supplied-pmid 34044077?><pub-id pub-id-type="pmid">34044077</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Song C, et al. Exploring the resources of the genus <italic>Viscum</italic> for potential therapeutic applications. J Ethnopharmacol. 2021;277:114233.<pub-id pub-id-type="pmid">34044077</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Slika</surname><given-names>H</given-names></name><etal/></person-group><article-title>Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms</article-title><source>Biomed Pharmacother</source><year>2022</year><volume>146</volume><fpage>112442</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2021.112442</pub-id><?supplied-pmid 35062053?><pub-id pub-id-type="pmid">35062053</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Slika H, et al. Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed Pharmacother. 2022;146:112442.<pub-id pub-id-type="pmid">35062053</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e6;b&#x000f8;</surname><given-names>IP</given-names></name><name><surname>Bj&#x000f8;r&#x000e5;s</surname><given-names>M</given-names></name><name><surname>Franzyk</surname><given-names>H</given-names></name><name><surname>Helgesen</surname><given-names>E</given-names></name><name><surname>Booth</surname><given-names>JA</given-names></name></person-group><article-title>Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity</article-title><source>Int J Mol Sci</source><year>2023</year><volume>24</volume><fpage>2914</fpage><pub-id pub-id-type="doi">10.3390/ijms24032914</pub-id><?supplied-pmid 36769243?><pub-id pub-id-type="pmid">36769243</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">S&#x000e6;b&#x000f8; IP, Bj&#x000f8;r&#x000e5;s M, Franzyk H, Helgesen E, Booth JA. Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity. Int J Mol Sci. 2023;24:2914.<pub-id pub-id-type="pmid">36769243</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Kundishora</surname><given-names>A</given-names></name><name><surname>Sithole</surname><given-names>S</given-names></name><name><surname>Mukanganyama</surname><given-names>S</given-names></name></person-group><article-title>Determination of the Cytotoxic Effect of Different Leaf Extracts from Parinari curatellifolia (Chrysobalanaceae)</article-title><source>J Toxicol</source><year>2020</year><volume>2020</volume><fpage>e8831545</fpage><pub-id pub-id-type="doi">10.1155/2020/8831545</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Kundishora A, Sithole S, Mukanganyama S. Determination of the Cytotoxic Effect of Different Leaf Extracts from Parinari curatellifolia (Chrysobalanaceae). J Toxicol. 2020;2020:e8831545.</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Paarvanova</surname><given-names>B</given-names></name><name><surname>Tacheva</surname><given-names>B</given-names></name><name><surname>Savova</surname><given-names>G</given-names></name><name><surname>Karabaliev</surname><given-names>M</given-names></name><name><surname>Georgieva</surname><given-names>R</given-names></name></person-group><article-title>Hemolysis by Saponin Is Accelerated at Hypertonic Conditions</article-title><source>Molecules</source><year>2023</year><volume>28</volume><fpage>7096</fpage><pub-id pub-id-type="doi">10.3390/molecules28207096</pub-id><?supplied-pmid 37894578?><pub-id pub-id-type="pmid">37894578</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Paarvanova B, Tacheva B, Savova G, Karabaliev M, Georgieva R. Hemolysis by Saponin Is Accelerated at Hypertonic Conditions. Molecules. 2023;28:7096.<pub-id pub-id-type="pmid">37894578</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Ziyyat</surname><given-names>A</given-names></name><etal/></person-group><article-title>Phytotherapy of hypertension and diabetes in oriental Morocco</article-title><source>J Ethnopharmacol</source><year>1997</year><volume>58</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(97)00077-9</pub-id><?supplied-pmid 9324004?><pub-id pub-id-type="pmid">9324004</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Ziyyat A, et al. Phytotherapy of hypertension and diabetes in oriental Morocco. J Ethnopharmacol. 1997;58:45&#x02013;54.<pub-id pub-id-type="pmid">9324004</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Freedman, J. C. &#x00026; Sperelakis, N. 13 - Diffusion and Permeability. in Cell Physiology Source Book (Third Edition) (ed. Sperelakis, N.) 209&#x02013;216 (Academic Press, San Diego, 2001). 10.1016/B978-012656976-6/50105-0.</mixed-citation></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Khursheed</surname><given-names>A</given-names></name><etal/></person-group><article-title>Efficacy of Phytochemicals Derived from Roots of Rondeletia odorata as Antioxidant, Antiulcer, Diuretic, Skin Brightening and Hemolytic Agents&#x02014;A Comprehensive Biochemical and In Silico Study</article-title><source>Molecules</source><year>2022</year><volume>27</volume><fpage>4204</fpage><pub-id pub-id-type="doi">10.3390/molecules27134204</pub-id><?supplied-pmid 35807450?><pub-id pub-id-type="pmid">35807450</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Khursheed A, et al. Efficacy of Phytochemicals Derived from Roots of Rondeletia odorata as Antioxidant, Antiulcer, Diuretic, Skin Brightening and Hemolytic Agents&#x02014;A Comprehensive Biochemical and In Silico Study. Molecules. 2022;27:4204.<pub-id pub-id-type="pmid">35807450</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JD</given-names></name><etal/></person-group><article-title>HPLC fractionation and pharmacological assessment of green tea seed saponins for antimicrobial, anti-angiogenic and hemolytic activities</article-title><source>Biotechnol Bioprocess Eng</source><year>2015</year><volume>20</volume><fpage>1035</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1007/s12257-015-0538-6</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Kim JD, et al. HPLC fractionation and pharmacological assessment of green tea seed saponins for antimicrobial, anti-angiogenic and hemolytic activities. Biotechnol Bioprocess Eng. 2015;20:1035&#x02013;43.</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Podolak I, et al<italic>.</italic> Saponins as cytotoxic agents: an update (2010&#x02013;2021). Part II&#x02014;Triterpene saponins. Phytochem Rev.&#x000a0;2023;22:113&#x02013;167.</mixed-citation></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Vo</surname><given-names>NNQ</given-names></name><name><surname>Fukushima</surname><given-names>EO</given-names></name><name><surname>Muranaka</surname><given-names>T</given-names></name></person-group><article-title>Structure and hemolytic activity relationships of triterpenoid saponins and sapogenins</article-title><source>J Nat Med</source><year>2017</year><volume>71</volume><fpage>50</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/s11418-016-1026-9</pub-id><?supplied-pmid 27491744?><pub-id pub-id-type="pmid">27491744</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Vo NNQ, Fukushima EO, Muranaka T. Structure and hemolytic activity relationships of triterpenoid saponins and sapogenins. J Nat Med. 2017;71:50&#x02013;8.<pub-id pub-id-type="pmid">27491744</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Marian</surname><given-names>MJ</given-names></name></person-group><article-title>Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits?</article-title><source>Nutr Clin Pract</source><year>2017</year><volume>32</volume><fpage>607</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1177/0884533617721687</pub-id><?supplied-pmid 28813230?><pub-id pub-id-type="pmid">28813230</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Marian MJ. Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits? Nutr Clin Pract. 2017;32:607&#x02013;27.<pub-id pub-id-type="pmid">28813230</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Vernieri</surname><given-names>C</given-names></name><etal/></person-group><article-title>Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives</article-title><source>Crit Rev Oncol Hematol</source><year>2018</year><volume>123</volume><fpage>57</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.critrevonc.2018.01.002</pub-id><?supplied-pmid 29482780?><pub-id pub-id-type="pmid">29482780</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Vernieri C, et al. Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives. Crit Rev Oncol Hematol. 2018;123:57&#x02013;73.<pub-id pub-id-type="pmid">29482780</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Bhori</surname><given-names>M</given-names></name><name><surname>Kasu</surname><given-names>YA</given-names></name><name><surname>Bhat</surname><given-names>G</given-names></name><name><surname>Marar</surname><given-names>T</given-names></name></person-group><article-title>Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity &#x02013; Exploring the armoury of obscurity</article-title><source>Saudi Pharm J SPJ</source><year>2018</year><volume>26</volume><fpage>177</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2017.12.013</pub-id><?supplied-pmid 30166914?><pub-id pub-id-type="pmid">30166914</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Singh K, Bhori M, Kasu YA, Bhat G, Marar T. Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity &#x02013; Exploring the armoury of obscurity. Saudi Pharm J SPJ. 2018;26:177&#x02013;90.<pub-id pub-id-type="pmid">30166914</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Block</surname><given-names>KI</given-names></name></person-group><article-title>Antioxidants and Cancer Therapy: Furthering the Debate</article-title><source>Integr Cancer Ther</source><year>2004</year><volume>3</volume><fpage>342</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1177/1534735404272152</pub-id><?supplied-pmid 15523105?><pub-id pub-id-type="pmid">15523105</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Block KI. Antioxidants and Cancer Therapy: Furthering the Debate. Integr Cancer Ther. 2004;3:342&#x02013;8.<pub-id pub-id-type="pmid">15523105</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Kennedy L, Sandhu J, Harper M, Cuperlovic-culf M. Role of Glutathione in Cancer: From Mechanisms to Therapies. Biomolecules. 2010;10:1429.</mixed-citation></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez Villarreal</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Preliminary Study of the Antimicrobial, Anticoagulant, Antioxidant, Cytotoxic, and Anti-Inflammatory Activity of Five Selected Plants with Therapeutic Application in Dentistry</article-title><source>Int J Environ Res Public Health</source><year>2022</year><volume>19</volume><fpage>7927</fpage><pub-id pub-id-type="doi">10.3390/ijerph19137927</pub-id><?supplied-pmid 35805583?><pub-id pub-id-type="pmid">35805583</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">L&#x000f3;pez Villarreal SM, et al. Preliminary Study of the Antimicrobial, Anticoagulant, Antioxidant, Cytotoxic, and Anti-Inflammatory Activity of Five Selected Plants with Therapeutic Application in Dentistry. Int J Environ Res Public Health. 2022;19:7927.<pub-id pub-id-type="pmid">35805583</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Mut-Salud</surname><given-names>N</given-names></name><etal/></person-group><article-title>Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results</article-title><source>Oxid Med Cell Longev</source><year>2016</year><volume>2016</volume><fpage>6719534</fpage><pub-id pub-id-type="doi">10.1155/2016/6719534</pub-id><?supplied-pmid 26682013?><pub-id pub-id-type="pmid">26682013</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Mut-Salud N, et al. Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results. Oxid Med Cell Longev. 2016;2016:6719534.<pub-id pub-id-type="pmid">26682013</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>C</given-names></name><etal/></person-group><article-title>Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent</article-title><source>Eur J Med Res</source><year>2023</year><volume>28</volume><fpage>297</fpage><pub-id pub-id-type="doi">10.1186/s40001-023-01271-8</pub-id><?supplied-pmid 37626424?><pub-id pub-id-type="pmid">37626424</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Zhou C, et al. Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent. Eur J Med Res. 2023;28:297.<pub-id pub-id-type="pmid">37626424</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Sanjai</surname><given-names>C</given-names></name><name><surname>Hakkimane</surname><given-names>SS</given-names></name><name><surname>Guru</surname><given-names>BR</given-names></name><name><surname>Gaonkar</surname><given-names>SL</given-names></name></person-group><article-title>A comprehensive review on anticancer evaluation techniques</article-title><source>Bioorganic Chem</source><year>2024</year><volume>142</volume><fpage>106973</fpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2023.106973</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Sanjai C, Hakkimane SS, Guru BR, Gaonkar SL. A comprehensive review on anticancer evaluation techniques. Bioorganic Chem. 2024;142:106973.</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">Mandisodza A. The Epidemiology of Leukaemia in Zimbabwe: A Ten Year Retrospective Study. Haematol Int J<italic>.</italic> 2017;1:1&#x02013;7.</mixed-citation></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><etal/></person-group><article-title>Global burden of hematologic malignancies and evolution patterns over the past 30 years</article-title><source>Blood Cancer J</source><year>2023</year><volume>13</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/s41408-023-00853-3</pub-id><pub-id pub-id-type="pmid">36599831</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Zhang N, et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023;13:1&#x02013;13.<pub-id pub-id-type="pmid">36599831</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Philippe</surname><given-names>G</given-names></name><etal/></person-group><article-title>In vitro screening of some Strychnos species for antiplasmodial activity</article-title><source>J Ethnopharmacol</source><year>2005</year><volume>97</volume><fpage>535</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2004.12.011</pub-id><?supplied-pmid 15740892?><pub-id pub-id-type="pmid">15740892</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Philippe G, et al. In vitro screening of some Strychnos species for antiplasmodial activity. J Ethnopharmacol. 2005;97:535&#x02013;9.<pub-id pub-id-type="pmid">15740892</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Scherf</surname><given-names>U</given-names></name><etal/></person-group><article-title>A gene expression database for the molecular pharmacology of cancer</article-title><source>Nat Genet</source><year>2000</year><volume>24</volume><fpage>236</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1038/73439</pub-id><?supplied-pmid 10700175?><pub-id pub-id-type="pmid">10700175</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Scherf U, et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet. 2000;24:236&#x02013;44.<pub-id pub-id-type="pmid">10700175</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>G-H</given-names></name><etal/></person-group><article-title>Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B</article-title><source>Cytotechnology</source><year>2015</year><volume>67</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/s10616-014-9761-9</pub-id><?supplied-pmid 25002206?><pub-id pub-id-type="pmid">25002206</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Qiu G-H, et al. Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B. Cytotechnology. 2015;67:1&#x02013;12.<pub-id pub-id-type="pmid">25002206</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Gul</surname><given-names>MZ</given-names></name><name><surname>Ahmad</surname><given-names>F</given-names></name><name><surname>Kondapi</surname><given-names>AK</given-names></name><name><surname>Qureshi</surname><given-names>IA</given-names></name><name><surname>Ghazi</surname><given-names>IA</given-names></name></person-group><article-title>Antioxidant and antiproliferative activities of Abrus precatorius leaf extracts - an in vitro study</article-title><source>BMC Complement Altern Med</source><year>2013</year><volume>13</volume><fpage>53</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-13-53</pub-id><?supplied-pmid 23452983?><pub-id pub-id-type="pmid">23452983</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Gul MZ, Ahmad F, Kondapi AK, Qureshi IA, Ghazi IA. Antioxidant and antiproliferative activities of Abrus precatorius leaf extracts - an in vitro study. BMC Complement Altern Med. 2013;13:53.<pub-id pub-id-type="pmid">23452983</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Pieme</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Antiproliferative activity and induction of apoptosis by Annona muricata (Annonaceae) extract on human cancer cells</article-title><source>BMC Complement Altern Med</source><year>2014</year><volume>14</volume><fpage>516</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-14-516</pub-id><?supplied-pmid 25539720?><pub-id pub-id-type="pmid">25539720</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Pieme CA, et al. Antiproliferative activity and induction of apoptosis by Annona muricata (Annonaceae) extract on human cancer cells. BMC Complement Altern Med. 2014;14:516.<pub-id pub-id-type="pmid">25539720</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="other">de Melo JG, Santos AG, de Amorim ELC, do Nascimento SC, &#x00026; de Albuquerque UP. Medicinal plants used as antitumor agents in Brazil: an ethnobotanical approach. Evid Based Complement Altern Med ECAM.&#x000a0;2011;2011:365359.</mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="other">Muruthi CW, Ngugi MP, Runo SM, &#x00026; Mwitari PG. In Vitro Antiproliferative Effects and Phytochemical Characterization of Carissa edulis ((Forssk) Vahl) and Pappea capensis (Eckyl and Zeyh) Extracts. J Evid Based Integr Med<italic>.</italic>&#x000a0;2023;28:2515690X231187711.</mixed-citation></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Ngulde</surname><given-names>SI</given-names></name><name><surname>Sandabe</surname><given-names>UK</given-names></name><name><surname>Abounader</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Hussaini</surname><given-names>IM</given-names></name></person-group><article-title>Activities of Some Medicinal Plants on the Proliferation and Invasion of Brain Tumor Cell Lines</article-title><source>Adv Pharmacol Pharm Sci</source><year>2020</year><volume>2020</volume><fpage>e3626879</fpage></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Ngulde SI, Sandabe UK, Abounader R, Zhang Y, Hussaini IM. Activities of Some Medicinal Plants on the Proliferation and Invasion of Brain Tumor Cell Lines. Adv Pharmacol Pharm Sci. 2020;2020:e3626879.</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Al-youssef</surname><given-names>H</given-names></name><name><surname>Hassan</surname><given-names>WHB</given-names></name></person-group><article-title>Phytochemical and Biological Studies of the Aerial Parts of Carissa Edulis Growing In Saudi Arabia</article-title><source>Biosci Biotechnol Res Asia</source><year>2016</year><volume>7</volume><fpage>635</fpage><lpage>646</lpage></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Al-youssef H, Hassan WHB. Phytochemical and Biological Studies of the Aerial Parts of Carissa Edulis Growing In Saudi Arabia. Biosci Biotechnol Res Asia. 2016;7:635&#x02013;46.</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>P</given-names></name><etal/></person-group><article-title>Anticancer activity and concurrent analysis of ursolic acid, &#x003b2;-sitosterol and lupeol in three different <italic>Hibiscus</italic> species (aerial parts) by validated HPTLC method</article-title><source>Saudi Pharm J</source><year>2018</year><volume>26</volume><fpage>1060</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2018.05.015</pub-id><?supplied-pmid 30416363?><pub-id pub-id-type="pmid">30416363</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Alam P, et al. Anticancer activity and concurrent analysis of ursolic acid, &#x003b2;-sitosterol and lupeol in three different <italic>Hibiscus</italic> species (aerial parts) by validated HPTLC method. Saudi Pharm J. 2018;26:1060&#x02013;7.<pub-id pub-id-type="pmid">30416363</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Lupeol and its derivatives as anticancer and anti-inflammatory agents: Molecular mechanisms and therapeutic efficacy</article-title><source>Pharmacol Res</source><year>2021</year><volume>164</volume><fpage>105373</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2020.105373</pub-id><?supplied-pmid 33316380?><pub-id pub-id-type="pmid">33316380</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Liu K, et al. Lupeol and its derivatives as anticancer and anti-inflammatory agents: Molecular mechanisms and therapeutic efficacy. Pharmacol Res. 2021;164:105373.<pub-id pub-id-type="pmid">33316380</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="other">Matata DZ, Ngassapa OD, Machumi F, &#x00026; Moshi MJ. Screening of Plants Used as Traditional Anticancer Remedies in Mkuranga and Same Districts, Tanzania, Using Brine Shrimp Toxicity Bioassay. Evid Based Complement Altern Med ECAM. 2018;3034612.</mixed-citation></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Canga</surname><given-names>I</given-names></name><name><surname>Vita</surname><given-names>P</given-names></name><name><surname>Oliveira</surname><given-names>AI</given-names></name><name><surname>Castro</surname><given-names>M&#x000c1;</given-names></name><name><surname>Pinho</surname><given-names>C</given-names></name></person-group><article-title>In Vitro Cytotoxic Activity of African Plants: A Review</article-title><source>Molecules</source><year>2022</year><volume>27</volume><fpage>4989</fpage><pub-id pub-id-type="doi">10.3390/molecules27154989</pub-id><?supplied-pmid 35956938?><pub-id pub-id-type="pmid">35956938</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Canga I, Vita P, Oliveira AI, Castro M&#x000c1;, Pinho C. In Vitro Cytotoxic Activity of African Plants: A Review. Molecules. 2022;27:4989.<pub-id pub-id-type="pmid">35956938</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="other">Ontiveros-Rodr&#x000ed;guez JC, Rojas-Rojas FU, Alonso-Castro AJ, &#x00026; Salazar-G&#x000f3;mez A. Chapter 6 - American mistletoes as a promising source of bioactive compounds. in <italic>S</italic>tudies in Natural Products Chemistry (ed. Rahman, A.) vol. 78 237&#x02013;253 (Elsevier, 2023).</mixed-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="other">Felenda JE, Turek C, &#x00026; Stintzing FC. Antiproliferative potential from aqueous <italic>Viscum album</italic> L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells. J Ethnopharmacol.&#x000a0;2019;236:100&#x02013;107.</mixed-citation></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Holandino</surname><given-names>C</given-names></name><etal/></person-group><article-title>Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts</article-title><source>BMC Complement Med Ther</source><year>2020</year><volume>20</volume><fpage>215</fpage><pub-id pub-id-type="doi">10.1186/s12906-020-02987-4</pub-id><?supplied-pmid 32646417?><pub-id pub-id-type="pmid">32646417</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Holandino C, et al. Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts. BMC Complement Med Ther. 2020;20:215.<pub-id pub-id-type="pmid">32646417</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>S-R</given-names></name><etal/></person-group><article-title>Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence</article-title><source>Br J Pharmacol</source><year>2020</year><volume>177</volume><fpage>1409</fpage><lpage>1423</lpage><pub-id pub-id-type="doi">10.1111/bph.14816</pub-id><?supplied-pmid 31368509?><pub-id pub-id-type="pmid">31368509</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Lin S-R, et al. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. Br J Pharmacol. 2020;177:1409&#x02013;23.<pub-id pub-id-type="pmid">31368509</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">Onyekere, P. F., Peculiar-Onyekere, C. O., Udodeme, H. O., Nnamani, D. O. &#x00026; Ezugwu, C. O. Biological Roles of Phytochemicals. in <italic>Phytochemistry</italic> (Apple Academic Press, 2018).</mixed-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="other">Guti&#x000e9;rrez-Grijalva, E. P., L&#x000f3;pez-Mart&#x000ed;nez, L. X., Contreras-Angulo, L. A., Elizalde-Romero, C. A. &#x00026; Heredia, J. B. Plant Alkaloids: Structures and Bioactive Properties. in <italic>Plant-derived Bioactives: Chemistry and Mode of Action</italic> (ed. Swamy, M. K.) 85&#x02013;117 (Springer, Singapore, 2020). 10.1007/978-981-15-2361-8_5.</mixed-citation></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Mondal</surname><given-names>A</given-names></name><name><surname>Gandhi</surname><given-names>A</given-names></name><name><surname>Fimognari</surname><given-names>C</given-names></name><name><surname>Atanasov</surname><given-names>AG</given-names></name><name><surname>Bishayee</surname><given-names>A</given-names></name></person-group><article-title>Alkaloids for cancer prevention and therapy: Current progress and future perspectives</article-title><source>Eur J Pharmacol</source><year>2019</year><volume>858</volume><fpage>172472</fpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2019.172472</pub-id><?supplied-pmid 31228447?><pub-id pub-id-type="pmid">31228447</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Mondal A, Gandhi A, Fimognari C, Atanasov AG, Bishayee A. Alkaloids for cancer prevention and therapy: Current progress and future perspectives. Eur J Pharmacol. 2019;858:172472.<pub-id pub-id-type="pmid">31228447</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Kopustinskiene</surname><given-names>DM</given-names></name><name><surname>Jakstas</surname><given-names>V</given-names></name><name><surname>Savickas</surname><given-names>A</given-names></name><name><surname>Bernatoniene</surname><given-names>J</given-names></name></person-group><article-title>Flavonoids as Anticancer Agents</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><fpage>457</fpage><pub-id pub-id-type="doi">10.3390/nu12020457</pub-id><?supplied-pmid 32059369?><pub-id pub-id-type="pmid">32059369</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as Anticancer Agents. Nutrients. 2020;12:457.<pub-id pub-id-type="pmid">32059369</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="other">Hazafa A, Rehman KU, Jahan N, &#x00026; Jabeen Z. The Role of Polyphenol (Flavonoids) Compounds in the Treatment of Cancer Cells. Nutr Cancer.&#x000a0;2020;72:386&#x02013;397.</mixed-citation></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Nozhat</surname><given-names>Z</given-names></name><name><surname>Heydarzadeh</surname><given-names>S</given-names></name><name><surname>Memariani</surname><given-names>Z</given-names></name><name><surname>Ahmadi</surname><given-names>A</given-names></name></person-group><article-title>Chemoprotective and chemosensitizing effects of apigenin on cancer therapy</article-title><source>Cancer Cell Int</source><year>2021</year><volume>21</volume><fpage>574</fpage><pub-id pub-id-type="doi">10.1186/s12935-021-02282-3</pub-id><?supplied-pmid 34715860?><pub-id pub-id-type="pmid">34715860</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Nozhat Z, Heydarzadeh S, Memariani Z, Ahmadi A. Chemoprotective and chemosensitizing effects of apigenin on cancer therapy. Cancer Cell Int. 2021;21:574.<pub-id pub-id-type="pmid">34715860</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Elekofehinti</surname><given-names>OO</given-names></name><name><surname>Iwaloye</surname><given-names>O</given-names></name><name><surname>Olawale</surname><given-names>F</given-names></name><name><surname>Ariyo</surname><given-names>EO</given-names></name></person-group><article-title>Saponins in Cancer Treatment: Current Progress and Future Prospects</article-title><source>Pathophysiology</source><year>2021</year><volume>28</volume><fpage>250</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.3390/pathophysiology28020017</pub-id><?supplied-pmid 35366261?><pub-id pub-id-type="pmid">35366261</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Elekofehinti OO, Iwaloye O, Olawale F, Ariyo EO. Saponins in Cancer Treatment: Current Progress and Future Prospects. Pathophysiology. 2021;28:250&#x02013;72.<pub-id pub-id-type="pmid">35366261</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Majnooni</surname><given-names>MB</given-names></name><etal/></person-group><article-title>Inhibiting Angiogenesis by Anti-Cancer Saponins: From Phytochemistry to Cellular Signaling Pathways</article-title><source>Metabolites</source><year>2023</year><volume>13</volume><fpage>323</fpage><pub-id pub-id-type="doi">10.3390/metabo13030323</pub-id><?supplied-pmid 36984763?><pub-id pub-id-type="pmid">36984763</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Majnooni MB, et al. Inhibiting Angiogenesis by Anti-Cancer Saponins: From Phytochemistry to Cellular Signaling Pathways. Metabolites. 2023;13:323.<pub-id pub-id-type="pmid">36984763</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Alexyuk</surname><given-names>PG</given-names></name><etal/></person-group><article-title>Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins</article-title><source>Arch Virol</source><year>2019</year><volume>164</volume><fpage>1793</fpage><lpage>1803</lpage><pub-id pub-id-type="doi">10.1007/s00705-019-04273-2</pub-id><?supplied-pmid 31079211?><pub-id pub-id-type="pmid">31079211</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Alexyuk PG, et al. Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins. Arch Virol. 2019;164:1793&#x02013;803.<pub-id pub-id-type="pmid">31079211</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><mixed-citation publication-type="other">Qasim, M., Islam, W., Ashraf, H. J., Ali, I. &#x00026; Wang, L. Saponins in Insect Pest Control. in <italic>Co-Evolution of Secondary Metabolites</italic> (eds. Merillon, J.-M. &#x00026; Ramawat, K. G.) 1&#x02013;28 (Springer International Publishing, Cham, 2019). 10.1007/978-3-319-76887-8_39-1.</mixed-citation></ref></ref-list></back></article>